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SUMMARY 
 
Irradiating T-47D cells with doses below 1 Gy revealed that cells of this line express hyper-
radiosensitivity (HRS). In the present study HRS has been investigated when a challenge dose 
was given 6 or 24 hours after a priming dose delivered with varying dose-rates. In addition the 
effect of a challenge dose to T-47D cells that had been pre-irradiated for several months by 
incorporated tritium was investigated. 
 
A 60Co-source at the Radium Hospital was used for all irradiations. It was chosen to give a 
fixed priming dose of 0.3 Gy, but dose-rates were varied between 0.045 Gy/h, 0.32 Gy/h, 0.9 
Gy/h or high dose-rate (HDR) of 1 Gy/min. Immediately after the priming exposure, the cells 
were trypsinized and seeded in small flasks (25 cm2) and incubated for 6 or 24 hours before 
they received the HDR challenge doses. 
 
DNA histograms revealed that the T-47D cells in the cell culture used in the experiments with 
priming exposures of 0.32 and 0.045 Gy/h and also in one of the experiments with HDR 
priming, had been mixed with cells of another stemline. The mixed cell culture (denoted T-
47Dmix) was also used in the experiment with incorporation of tritium into T-47d cells, but in 
this case it was found from DNA histograms that only the control cells were mixed, but that 
the cultures exposed to protracted low dose-rate (LDR) irradiation consisted of only T-47d 
cells. Investigations were made that suggested that the cells mixed into the T-47D cells were 
of the line NHIK 3025. 
 
The following was observed from the experiments: 
 
• T-47D cells clearly express both HRS/IRR and the adaptive response in the low-dose 
range (below 1 Gy).  
 
• NHIK 3025 cells do not express HRS/IRR. 
 
• T-47D cells that had been pre-irradiated by tritium-decay electrons did not express 
HRS/IRR. 
 
• T-47D cells with functional pRb adapted to the continuous irradiation with electrons 
from incorporated tritium, while the putative NHIK 3025 cells without functional pRb 
were eradicated by the same treatment. 
 
• When priming doses were delivered with the lowest dose-rates used (i.e. 0.32 Gy/h 
and 0.045 Gy/h) the priming effect as measured 6 hours following the termination of 
the priming exposure seemed to be larger than when the priming dose was delivered 
with higher dose-rates (i.e. HDR or 0.9 Gy/h). 
 
• 24 hours after the priming doses delivered with 0.32 Gy/h and 0.045 Gy/h, HRS was 
still absent (perhaps even further reduced), while 24 hours after a HDR priming dose 
HRS was partially restored. 
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These results led to speculations concerning: 
 
• The influence of micro-environmental conditioning effects on the radiation response of 
NHIK 3025 cells that are growing in a mixed culture with T-47D cells under 
conditions that would normally be lethal for NHIK 3025 cells. 
 
• An alternative theory for HRS/IRR in which it is assumed that the repair processes of 
the cell are permanently induced. When radiation damages are so small, that the tissue 
as a whole would profit from cell suicide relative to repair with the danger of mis-
repair, the repair processes are subdued by apoptosis. 
 
• The involvement of pRb in the suppression of apoptosis of the alternative theory for 
HRS/IRR and in the adaptation of T-47D cells to continuous irradiation by decay 
electrons from incorporated tritium. 
 
• The possibility that there are two different regulation pathways for induction of the 
cell-protective mechanisms that reduce HRS after pre-irradiation: One that is dose 
dependent, instantly induced by HDR irradiation but not by LDR irradiation, and 
which induces short-lasting mechanisms. Another pathway that works over time and is 
induced by LDR and probably also by HDR irradiation. The effect and duration of the 
mechanisms induced by this late-responding pathway depends on the duration of 
exposure. 
 
 
For any conclusions to be drawn, further investigations are required. 
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ABBREVIATIONS AND DESIGNATIONS  
 
 
Acute irradiation: Irradiation given with a dose-rate of ~1 Gy/min or higher. 
 
Counter-HRS effect The abolition of low dose HRS in response to a preceding 
exposure.  
 
HDR:  High dose-rate (~1 Gy/min or higher). 
 
HRS:   Hyper-radiosensitivity. Used only in connection with response to 
doses below 1 Gy. 
 
IR-model:   Induced repair model. 
 
IRR:  Induced-radio-resistance- used only in connection with response 
to doses below 1 Gy. 
 
LDR:   Low dose-rate. 
 
LQ-model:   Linear quadratic model. 
 
pRb:  Protein of retinoblastoma gene (tumor suppressor). 
 
T-47Dmix   Used as designation of the T-47D cell culture that had another 
stem line mixed into it. 
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1 INTRODUCTION 
Treatment of cancer using radiotherapy implies not only finding the best regime for rate and 
fractionation of dose delivery for killing of the cancer cells. An even greater concern is to 
obtain utmost sparing of the normal tissue. A precise knowledge of the biologic effect of 
radiation is thus necessary when treatment plans are made for the patient. During external 
radiation therapy not only the tumor is irradiated, the normal tissue in the penumbra will also 
receive a radiation dose. In brachytherapy radioactive material is implanted either directly into 
the tumor (interstitial therapy) or close to it inside a catheter (intercavitary therapy). In this 
case the normal tissue surrounding the target is irradiated at dose-rates diminishing with the 
distance from the source.  
 
In the clinic doses are traditionally given as 2 Gy doses with 24 hour intervals but also 
regimens with smaller doses with a shorter interval between are used in order to exploit the 
difference in sparing between late and early responding tissues as a consequence of dose 
fractionation.  
 
In many mammalian cells, a region of high sensitivity in the radiation survival response at 
doses below ~0.5 Gy has been observed. This phenomenon has been termed hyper-
radiosensitivity (HRS). It precedes the occurrence of a relative resistance to cell killing by 
radiation over the dose range ~0.5-1 Gy, which has been termed increased radioresistance 
(IRR) (Joiner and Johns, 1988 and Joiner et al., 2001). In the HRS dose range a reverse 
fractionation effect may be expected if doses are administered in a way that allows the 
hypersensitive response to be repeated. In order to be able to exploit HRS in radiotherapy and 
predict the effects of a particular treatment, it is important to investigate the dependence of the 
response of low dose HRS to a preceding exposure (here denoted a priming dose). Both the 
size and dose-rate of the priming dose and the interval between this and the subsequent doses 
are parameters that need closer investigation.  
 
The preliminary experiments of this study revealed a hypersensitive response to low doses of 
-radiation in T-47D cells that was not expected. In fact the original intention was to 
investigate effects of pulsed dose-rate in two cell lines, one with and one without 
hypersensitivity; V79 cells were chosen as the cell line with known HRS/IRR and T-47D cells 
as the cell line believed to be without HRS/IRR. Instead experiments T1-T6 and V1-V6 
revealed a larger response to doses below 1 Gy for T-47D cell than for V 79 cells. This 
encouraged further investigations into the phenomena of hypersensitivity and adaptive effects 
as responses to low doses for T-47D cells. 
 
The aim of this study became to investigate the influence of a priming dose on the radiation 
response of T-47D cells when the priming dose was delivered with different dose-rates. The 
priming dose was chosen to be 0.3 Gy. This dose was large enough to reduce HRS when cells 
were given a subsequent challenge dose, but so small that a complete induced IRR was not 
seen. 
 
Furre et al. (2003) found that pRb was activated by radiation delivered with dose-rates of 0.3 
and 0.9 Gy/h. We expected a counter-HRS effect of priming doses delivered with HDR, which 
we also found, and wanted to investigate how low the dose-rate had to be for the counter-HRS 
effect not to be induced. Experiments were performed with four different dose-rates of the 
priming dose: In addition to HDR, 0.9 and 0.3 Gy/h were chosen because the irradiation set-
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up was established by Furre et al., and the dose-rate was further lowered to 0.045 Gy/h in the 
attempt to find the lowest dose-rate of the priming dose eliciting a counter-HRS effect. In all 
these experiments a counter-HRS effect was observed. 
 
In experiments without priming exposure T-47D cells express HRS. This implies that the 
dose-rate of background irradiation is too low for the counter-HRS effect to be induced. Thus, 
there must exist a dose-rate lower than 0.045 Gy/h that does not induce the counter-HRS 
effect. When it comes to administering dose-rates lower than 0.045 Gy/h, external irradiation 
has limitations. The cells will need exchange of medium during irradiation and it can be a 
problem to have the irradiation facilities at disposal for longer periods.   
 
A method for internal irradiation was developed by Søvik (2002), who irradiated T-47D cells 
by incorporation of tritium and established the dosimetry for 2 different dose-rates. The lowest 
dose-rate was 0.01 Gy/h to the cell nucleus. At this dose-rate the cells were found to adapt to 
the continuous irradiation. We wanted to investigate whether the mechanisms behind this 
adaptation is related to those that induce the counter-HRS effect , and experiments were 
performed in which cells that had been pre-irradiated by electrons from incorporated tritium 
for several months were challenged by HDR irradiation. 
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 2 THEORY  
2.1 CELL BIOLOGY 
Chapters 2.1.1.and 2.1.2 are based upon (Alberts et al., 1994) and (Hall, 2000). 
2.1.1 THE CELL CYCLE 
Cells proliferate by division after duplicating their contents. This is a cyclic phenomenon 
known as the cell cycle. 
 
The cell cycle is traditionally divided into interphase and mitosis (M-phase). During mitosis 
which in most cells takes about an hour, the nuclear envelope disintegrates and the DNA 
condense into visible chromosomes that align on the mitotic spindle (metaphase) after which 
the cromatides separate and move to the poles of the spindle (anaphase). The nuclear envelope 
is re-created and the cromatides decondense (telophase). The M-phase ends with cytokinesis 
dividing the cell into two new cells. Interphase, the interval between two consecutive mitoses, 
consists of the phases G1, S, and G2. The replication of the cell’s DNA takes place during S-
phase (S=synthesis), while the G1- and G2-phases (G=gap) provide time for cell growth and 
preparation for replication and mitosis, respectively. The lengths of all the phases vary to 
some extent between different cells under different circumstances, but the greatest variation 
occurs in the length of the G1-phase. From G1 the cell can exit the cycle and enter a quiescent 
state G0; some cells are terminally differentiated to perform their function in the organism, 
while other cells after a longer or shorter period in G0 re-enter into the cycle. 
 
2.1.2 CELL CYCLE REGULATION 
Cytoplasmic proteins that are activated by the enzymatic activity (phosphorylation) of cyclin-
dependent kinases (cdks) control transitions from one cell cycle phase to the next. Cdks levels 
remain stable during cell cycle, but each cdk must bind the appropriate cyclin in order to be 
activated. Each cyclin protein is synthesized at a discrete phase and is degraded after fulfilling 
its purpose so that cyclin levels oscillate as the cell goes through cell cycle (figure 2.1). 
 
 
 
Figure 2.1: Oscillation of cyclin 
levels with phase of cell cycle. 
Progression through the cell cycle 
is governed by protein kinases, 
activated by cyclins (Hall, 2000). 
 
 
The “decision” to proceed in the cycle is evaluated at checkpoints where feedback signals 
ensure that previous processes are completed before the next one is initiated. Two major 
checkpoints, G1k and G2k are located prior to the transitions into S and M. These checkpoints 
allow extracellular signals to effect on the control system and also retain the cells in case of 
DNA damage in order to provide time for repair before replication or mitosis. Radiation- 
induced damage can also cause a delay in G2 at a separate point before G2k (G2-block) 
preventing propagation of defective DNA. In case of DNA being damaged after passing G1k 
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the cell has mechanisms for depressing the replication until the damage is repaired, and in the 
metaphase of mitosis the proper alignment of the chromosomes is ensured at another 
restriction point. 
  
In the rest state G0 is also an important checkpoint, G0k, where the amount of growth factor 
decides whether the cell should enter the cell cycle and start proliferation. The growth factor 
receptors are located on the cell membrane and activate, when stimulated, intracellular 
phosphorylation cascades that lead to expression of proliferation genes (proto-oncogenes) 
bringing the cell past G0k. A mutation leading to over-expression of the proliferation gene will 
increase cell proliferation, and the gene is called an oncogene. Only mutation in one of the 
cell’s two copies of the proliferation gene needs to be overactivated in order to result in cancer 
development. Excessive cell proliferation can also be caused by inactivating mutations in both 
copies of an antiproliferation gene (tumour suppressor gene) since the proteins from these 
genes act like brakes inhibiting cell division. The genes encoding the proteins p53 and pRb are 
important tumour suppressor genes. 
 
When activated, p53 enhances transcription of another regulatory gene (p21WAF1/CIPI) 
resulting in the inhibition of G1 cyclin/cdks, that normally would phosphorylate pRb releasing 
it from its growth-suppressive function (Hall, 2000), thus preventing the progression from G1 
into S. Under normal conditions the p53 concentration is kept very low by its relatively short 
half-life (about 20 min.) (Levine, 1997). At exposure to ionizing radiation the concentration 
increases rapidly, preventing the cell to enter S with damaged DNA either by retaining it at 
G1k or if repair fails, by inducing apoptosis. Mutations of the p53 gene are present in more 
than 50 % of all cancer cases. 
 
pRb is the protein of the retinoblastoma gene (Rb) and was identified through studies of an 
inherited predisposition to eye cancer in children. It is abundantly present in the nucleus of 
mammalian cells but the activation is regulated by the state of phosphorylation. When 
dephosphorylated, pRb is activated and binds regulatory proteins while phosphorylated pRb 
releases these proteins to induce gene transcription required for cell proliferation (figure 2.2). 
In G0 pRb is dephosphorylated inhibiting proliferation. In proliferating cells, the 
phosphorylation of pRb rises late in G1 and remains high through S and G2 before pRb returns 
to a dephosphorylated form in mitosis.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: pRb is dephosphorylated and active preventing transcription of regulatory genes 
from the end of mitosis until late in G1. Phosphorylated pRb is inactive which permits the 
regulatory proteins to induce gene transcription required for the cell to proceed through cell 
cycle (Alberts et al., 1994). 
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2.2 RADIOBIOLOGY 
The radiation used to irradiate the cell flasks in the experiments conducted here and the 
radiation from incorporated tritium both originate from radioactive decay. When a radioactive 
nucleus disintegrates, energy is emitted as radiation that can be either particulate, 
electromagnetic or both. It is not possible to know when a particular atom will decay, but in a 
large number of atoms the proportion that will disintegrate in a given time is predictable. The 
number of atoms disintegrating per unit time, dN/dt, is proportional to the number of 
radioactive atoms N: 
 N
dt
dN λ−=  (2.1) 
where λ is a constant of proportionality called the decay constant. The solution to (2.1) is: 
 
teNN λ−= 0  (2.2) 
where N0 is the initial number of radioactive atoms. 
The activity A is defined as the rate of decay: 
 
 NA λ−=  (2.3) 
 
which is measured in Becquerel [Bq] or in curie [Ci]. 
1 Bq = 1 decay per second = 2.7×10-11 Ci. 
The half-life, T1/2, of a radioactive substance is defined as the time required for the number of 
radioactive atoms to be reduced to half of the initial number. T1/2 is found from: 
 
λ
2ln
2
1 =T
 (2.4) 
2.2.1 IONIZING RADIATION 
Ionizing radiation, particulate or electromagnetic, is characterized by the ability to ionize an 
atom of the matter with which it interacts. From this follows that it must carry energy in 
excess of the amount needed by a valence electron to escape an atom, which is in the order of 
4-25 eV (Attix 1986). The biologic effects of radiation result principally from damage to 
DNA, which is the critical target (Hall 2000). 
 
In these experiments a cobalt-60 source was used. In the cobalt-60 unit the emission of two 
photons, one at 1.17 MeV and the other at 1.33 MeV (Attix 1986) accompany each 
disintegration. At these energies the Compton process dominates (Hall 2000). The energy of 
the photon is so high that the binding energy of the electron of an atom in the absorbing 
material is negligible and the electron may be regarded as free. Part of the energy and 
momentum of the incoming photon is transferred to the electron and the photon is deflected 
from its original path with the remaining energy; the fraction lost may vary from 0 to 80%. 
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Thus the incoming γ-radiation can result in a large number of fast electrons able to cause 
biologic damage. 
 
When the radiations interact directly with the critical targets in the cell, it is called direct 
action of radiation. In the cell the biomolecules are surrounded by water and the indirect 
action dominates; the critical target is damaged by free radicals created through interactions of 
the radiation with other atoms or molecules, particularly water. A free radical has an unpaired 
electron in the outer orbit, is highly reactive chemically, and is able to diffuse a short distance 
to reach the critical target. It is estimated that two thirds of the damage to DNA by x-rays is 
caused by the hydroxyl radical (Hall 2000) which arise from the following reactions: 
 
H2O → H2O+ + e- 
H2O+ + H2O → H3O+ + OH
⋅
  
 
Changes in the bases of the nucleic acid, breakage in the strands of the double helix, and 
abnormal cross-links formed in the DNA or between the DNA and cellular proteins, are 
believed to be the lesions leading to point mutations (changes of the molecular structure of 
DNA) (Nias 1998).  
 
TRITIUM 
 
In some of the experiments conducted here, the cells had been exposed to radiation from 
incorporated tritium previous to the external irradiation. 
Tritium disintegrates to the stable helium isotope 3He emitting an electron and an anti- 
neutrino: 
 
 
νβ ++→ HeH 33
  
The energy released in the disintegration process is divided between the electron and the anti-
neutrino resulting in a continuous energy spectrum with maximum electron energy per 
disintegration of 18.6 keV and mean electron energy of 5.75 keV. The recoil energy of the 
helium nucleus varies from 0 to about 3 eV which is too little to break molecular bonds 
(Feinendegen, 1967). 
 
The range of the electrons is the expectation value of the path length that it follows until it 
comes to rest. In the continuous slowing down approximation (CSDA), the range in terms of 
the mass stopping power is defined as: 
 
 
dT
dx
dTR
T
CSDA
1
0
0
−
 





=
ρ
 (2.5) 
Where ρ is the density of the absorber and T0 is the starting energy of the electron. The 
stopping power (dT/dx) is the expectation value of the rate of energy loss per unit path length 
for electrons with kinetic energy T in a given medium. 
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The range of the electrons in water (for dosimetric purposes, cells are considered water 
equivalent) is 6 µm corresponding to 18.6 keV and 1 µm corresponding to 5.75 keV (ICRP, 
1983). The diameter of T-47D cells was found by Åste Søvik (2002) to be 19±1 µm, the 
nucleus diameter 13±1 µm. 
 
 
2.2.2 CELLULAR RESPONSE TO RADIATION  
The radiosensitivity of the cells varies as they go through cell cycle. In general, cells are most 
radiosensitive in G2 and M, while they are most resistant in the latter part of S-phase. For cells 
with a relatively long G1-phase, there is a resistant period early in G1, followed by a sensitive 
period toward the end of G1 (Hall 2000). 
 
The radiation damage to cells can be categorized as lethal, sublethal, or potentially lethal 
damage (Hall 2000).  
 
Lethal damage is irreversible and irreparable, leading to cell death.  
 
Sublethal damage can be repaired within a few hours unless additional sublethal damage arise 
with which it can interact to form lethal damage. Reparation of sublethal damage is believed 
to be the explanation of the increase in cell survival observed when the radiation dose is split 
into two fractions separated by a time interval.  
 
Potentially lethal damage will under normal conditions (cells growing exponentially at 37°C) 
lead to cell death, but can be repaired if the postirradiation conditions are suboptimal for 
growth. Also a delay in the cell cycle giving the cell time for repair before S-phase or mitosis 
can be provided by p53 retaining the cell at G1k or by radiation induced enzymes in G2 (G2 
block) (Alberts 1994). 
 
The most common cell death from radiation is mitotic death, where the cells die attempting to 
divide, because of damaged chromosomes. This doesn’t necessarily happen during the first 
mitosis following irradiation; the cell may go through a few cycles before succumbing to 
destiny. The cells swell and burst in a process called necrosis. The result is that the cytosolic 
contents end up in the extracellular space provoking an inflammatory response. 
 
A way of death, more advantageous to the organism, is the programmed cell death, apoptosis: 
The cell undergo morphologic changes eventually separating into a number of membrane-
bound fragments, that are phagocytosed by macrophages, disassembled, and reused (Hall, 
2000; Alberts et al., 1994). Apoptosis after irradiation seems to be a p53-dependent process 
(Hall 2000). 
 
In general, cells that have lethal DNA damage are no risk for the organism with respect to 
later cancer development. It is when repair processes are active, the danger of mis-repair and 
possible subsequent inactivation of tumour suppressor genes or activation of oncogenes, is 
present (Alberts et al., 1994). 
.  
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2.2.3 CELL SURVIVAL CURVES 
When recording the effect of irradiation on cells, an end-point must be chosen. For cells in 
vitro, as used in these experiments, the loss of reproductive integrity is normally used. A 
surviving (clonogenic) cell is defined as a cell able to form a colony of 40-50 cells (5-6 
generations) (Steel, 1997). 
 
A cell-survival curve describes the relationship between the radiation dose and the fraction of 
cells that survive. It is usually presented in a semi-logarithmic plot with the fraction of 
surviving cells as the logarithmic ordinate and dose as the abscissa. For densely ionizing (high 
Linear Energy Transfer LET) radiation the survival approximates an exponential function of 
dose and the curve is a straight line. For x- or γ-rays (sparsely ionizing or low LET) the dose-
response curve has an initial linear slope, followed by a shoulder where the curve bends. For 
very high doses the curve often straightens again (Hall, 2000) (figure 2.3). 
 
The survival curves are best described by the linear-quadratic (LQ) model (Sinclair, 1966). It 
is assumed that there are two components to cell inactivation by radiation: One proportional to 
dose and one proportional to the square of the dose. The expression for the survival curve is  
 
2DDeS βα −−=
 (2.6) 
in which S is the survival fraction, D is dose, and α and β are constants. The same equation 
was derived by Chadwick and Leenhouts from the assumption that cell inactivation is a 
consequence of double-strand break in DNA (Chadwick and Leenhouts, 1973). If a single 
particle breaks both strands, ln(S) is proportional to the dose. In the case of two independent 
particles breaking each a strand close enough in time and space to function as a DSB, ln(S) is 
proportional to the square of the dose.  
 
 
 
 
 
 
Figure 2.3: Cell survival curves for radiation 
with high and low LET. Neutrons and α-rays 
(high LET) result in a dose response curve of a 
straight line. For x- and γ-rays (low LET) an 
initial linear slope is followed by a curved part 
(the shoulder) which for high doses tends to 
straighten out. (Hall, 2000, modified) 
 
 
The ratio α/β is the dose at which the linear and quadratic components of cell killing are 
equal, that is αD = βD2, and this fraction determines the size and shape of the shoulder of the 
cell-survival curve (figure 2.3). At least two sublethal damage sites are needed to inactivate a 
cell. At low doses, the cell may be able to repair a SLD before a new damage is induced which 
is reflected in a lower cell kill; as the SLDs accumulate, damages that are not lethal in 
themselves will lead to cell death in combination with the SLDs and the survival curve bends. 
The size of the shoulder thus reflects the amount of repair of sublethal damage (SLD); a broad 
shoulder corresponding to a small α/β ratio indicates a substantial amount of SLD repair and 
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is characteristic of late-responding tissues, while tumour- and early responding tissues have a 
large α/β ratio with α dominating at low doses (figure 2.4) (Hall, 2000).   
 
The LQ-model predicts a continuously bending curve for higher doses. This is not concordant 
with experimental observations, but in the range of doses relevant to clinical radiotherapy the 
LQ-representation seems to be adequate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Dose-response curves for late 
and early responding tissues characterized 
by a small and large α/β ratio, respectively 
(Hall, 2000). 
 
HYPERSENSITIVITY AND INDUCED RADIORESISTANCE 
At doses smaller than 1 Gy, many cell lines show a deviation from the linear-quadratic curve, 
and the LQ model substantially underestimates the effect of single x- or γ-ray doses (figure 
2.5). A region of hyperradiosensitivity (HRS) (doses below ~0.5 Gy) precedes the occurrence 
of a relative resistance per unit dose to cell killing by radiation, called increased 
radioresistance (IRR) (dose range ~0.5-1 Gy) (Joiner et al., 2001). Joiner and Johns (Joiner et 
al., 1988) proposed a modification to the linear-quadratic representation, the so-called IR 
(Induced Repair) model in which α decreases with increasing X-ray dose to represent the 
induced radioresistance. The α in equation (2.2) is replaced by: 
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where Dc represents the dose at which 63 % ((1 – e-1)%) of induction has occurred . αr is the 
initial slope of the curve using the LQ-model and αs  the corresponding slope for the IR-model 
(see figure 2.5) (Marples and Joiner 1993). 
 
Low dose hypersensitivity and increased radioresistance have been observed in synchronised 
cell populations and this indicates that cell cycle-related variations in sensitivity do not 
explain these phenomena (Wouters and Skarsgard, 1997). Instead, the increased radioresistant 
response seems to result from the activation of a DNA repair process which is triggered by 
increasing levels of cellular damage. The dependence of IRR on protein synthesis is evident 
from experiments where cells failed to show IRR after exposure to inhibitors of DNA repair-
protein transcription (Marples and Joiner, 1995 and 2000). In the part of the survival curve 
preceding the IRR response the amounts of damage are insufficient to trigger the mechanisms 
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of IRR and the result is a hypersensitive dose-response. The existence of HRS can be seen as a 
way to protect the organism by removing damaged cells that could represent a potential risk 
for carcinogenesis. As the number of damaged cells increases, a removal would threaten the 
integrity of the organism and IRR secures maximum recovery from the instant insult with the 
risk of misrepair eventually leading to cancer. 
 
HRS/IRR has been seen in 76% of more than 45 cell lines investigated (Joiner et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Survival of asynchronous T98G 
human glioma cells irradiated with 240 kVp x-
rays. The solid and dashed line show the fits of 
the induced repair (IR) model and linear-
quadratic (LQ) model, respectively. αr is the 
slope of the LQ-fit, αs  of the IR-fit (Joiner et al., 
2001). 
 
 
2.2.4 ADAPTIVE RESPONSE 
A small priming dose may protect against a subsequent, separate, exposure to radiation. This 
is called the adaptive response and seems to be related to the HRS/IRR mechanism as it also 
arises from the radioprotective mechanisms, or stress responses, that are upregulated in 
response to small doses of ionizing radiation and other DNA-damaging agents (Joiner et al., 
1996). In experiments with V 79 cells, both the induction of increased radioresistance after 
single doses of x-rays and the adaptive response was inhibited by cycloheximide, which 
demonstrates the need for protein synthesis in both induced-resistance phenomena (Marples 
and Joiner, 1995) and this indicates that DNA repair mechanisms are likely to be involved in 
the adaptive response as well as in IRR. However, Wouters and Skarsgard (1997) found that a 
priming dose given to HT29 cells, which demonstrate HRS, abolished the hypersensitive 
response to small doses, but did not induce an adaptive response for higher doses. Also the 
interval between two doses, required to remove an adaptive response is much longer than the 
corresponding interval to allow HRS to recur (Mitchell and Joiner, 2002). This suggests that 
IRR and the adaptive response are two different mechanisms of increased radioresistance 
(Short et al., 2001). Induction of the adaptive response has been found to be dependent upon a 
number of factors including the adapting dose, dose-rate, expression time, culture conditions, 
and stage of the cell cycle (Cregan et al., 1999). 
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2.2.5 FRACTIONATED IRRADIATION 
When the dose is given in fractions, the cells will have time to repair sublethal damage before 
the next fraction is given. This implies that the shoulder of the survival curve is repeated at 
each fraction resulting in a sparing effect. Since the shoulders for early responding tissues are 
small (corresponding to large α⁄β ratios), whereas the shoulders for late effects are large 
(small α⁄β ratios), the sparing effect will be much more pronounced for the late-responding 
tissue (figure 2.6).  
 
When a tumour grows the required induction of blood supply is provided by angiogenesis. 
This new blood supply may be inadequate resulting in hypoxic areas viable at least for a time. 
The presence of oxygen during irradiation enhances the radiosensitivity as the oxygen fixes 
the damage caused by free radicals produced by radiation, which means that hypoxic areas are 
less sensitive to radiation (Steel, 1997). The damage to the tumour tissue may therefore be 
increased by fractionation because the time between fractions allow reoxygenation and also 
reassortment of cells into radiosensitive phases of the cell cycle. The overall treatment time is 
restricted by the possible proliferation of surviving tumour cells (Hall, 2000). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Effect of dose fractionation on 
survival curves of A: early responding tissues 
represented by bone marrow stem cells, and B: 
late-responding tissues represented by cells 
responsible for radiation pneumonitis (Peters et 
al., 1979. Nias, 1998). 
 
 
2.2.6 LOW DOSE-RATE IRRADIATION 
Dose-rate is one of the principal factors that determine the biologic consequences of a given 
absorbed dose of x- or γ-rays. As dose-rate is lowered, the time taken to deliver a particular 
radiation dose increases, and biological processes that take place during irradiation modify the 
observed radiation response. The dose-rate effect results from the repair of sublethal damage. 
The continuous low dose-rate irradiation may be considered to be an infinite number of 
infinitely small fractions, and the shoulder of the survival curve is repeated with each fraction 
resulting in a straight line, with the shoulder disappearing and the curve getting shallower as 
the dose-rate is reduced (dose-rate sparing). The dose-rate effect caused by repair of sublethal 
damage is most pronounced between 0.01 and 1 Gy/min (Hall, 2000). The magnitude of the 
dose-rate effect is related to the size of the shoulder of the survival curve for acute exposure 
since both are expressions of the cell’s capacity to accumulate and repair sublethal damage. 
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Instead of a dose-rate sparing response, some cell lines demonstrate an inverse dose-rate effect 
at dose-rates below 1 Gy/h (Mitchell et al., 2001), in which decreasing the dose-rate results in 
increased cell killing per unit dose. An explanation to this phenomenon was proposed by 
Mitchell (Mitchell et al., 1979): Since cells move out of G2 phase only when most of the 
radiation induced damage is successfully repaired, an accumulation in G2 will take place when 
cell are being constantly irradiated and not are able to repair all damage. As G2 is the most 
radiosensitive phase of the cell cycle, this will result in an increased cell kill. A further 
reduction in dose-rate will allow the cells to escape the G2 block and proliferation may occur 
during irradiation leading to a reduction in biologic effect. This is summarized in fig. (2.7). 
 
 
 
 
 
 
Figure 2.7: The dose-rate effect. As dose-rate is 
reduced, the dose-response curve gets shallower as 
a result of sublethal damage repair. In some cell 
lines redistribution to a radiation-sensitive cell 
cycle phase will lead to a lower survival as the 
dose-rate is reduced. Further reduction of dose-
rate allows escape from the G2-block and the curve 
gets shallower as a result of proliferation (Hall, 
2000). 
 
 
Another explanation to the inverse dose-rate effect suggested by Cao et al. (1983) is the lack 
of induction of repair processes at the lowest dose-rates. Experiments by Mitchell et al. (2002) 
confirm this relation to the hypersensitivity at low doses as they found an inverse dose-rate 
effect only in the cell lines known to show HRS/IRR at low acute doses. Cells of a HRS/IRR-
negative cell line showed a sparing effect.  
 
2.3 DOSIMETRY 
2.3.1 DEFINITIONS 
The following is based on Attix, 1986. 
The energy imparted by ionizing radiation to matter of mass m in a finite volume m is defined 
as (ICRU, 1980): 
 +−+−= QRRRR coutcinuoutuin )()()()(ε  (2.8) 
where (Rin)u  and (Rin)c is the radiant energy of uncharged and charged radiation, respectively, 
entering V, and (Rout)u and (Rout)c is the corresponding energy leaving V. Q is the net energy 
derived from rest mass in V. 
 
The absorbed dose D at a point P in a finite volume V can be defined as:  
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dm
dD ε=
 (2.9) 
where dm is the mass in the infinitesimal volume dv and dε is the expectation value of the 
energy imparted in dv. 
The absorbed dose is thus a measure of the radiation energy that remains in the matter where it 
may produce biologically significant effects. 
The unit used for absorbed dose is the Gray [Gy], and is defined as: 1 Gy = 1 J/kg. 
 
 
The absorbed dose-rate at a point P and time t is given by: 
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2.3.2 TRITIUM DOSIMETRY 
The dosimetry of the incorporated tritium was estimated by Åste Søvik (2002). 
Because of the very short range of the electrons emitted by tritium compared to the size of the 
cells, the dosimetry of cellular systems is complicated by the lack of homogeneity both in the 
composition of the cell and in the distribution of the radioactive tritium. The critical target for 
radiation is considered to be the DNA in the cell nucleus, but the tritium will be distributed 
also in the cytoplasm as it is built into a certain fraction of the proteins synthesized after the 
addition of the tritiated valine. Both electrons generated in the nucleus and in the cytoplasm 
can contribute to the nuclear dose but can also deposit their energy outside the nucleus or the 
cell. An inhomogeneous distribution of radioactivity between the cell nucleus and its 
surroundings would result in more energy transported out of the volume with higher activity 
than received from the one with lower activity. In addition the course of the particle is 
deflected by inelastic scattering and the stopping power of the electron will vary as they slow 
down and loose energy. 
 
A model introduced by Goddu et al. (1997) was used, where the cell was regarded as two 
concentric spheres both with density 1 g/cm3 and with a homogeneous distribution of 
radioactivity within the cytoplasm and cell nucleus, respectively. A number of factors are not 
included in this model. The energy transported out of the target area by delta-electrons (very 
fast secondary electrons) was considered to be of little importance for low-energy electrons, 
the dose contribution from emitters outside the cell was considered negligible, and the 
curvature of the electron course was ignored because of the large dimensions of the cell and 
cell nucleus compared to the electron range. The model will not be able to give the dose-rate 
given to a single cell with a particular size, cell geometry, intracellular activity, and 
distribution of energy deposit, but only an estimate of the average dose-rate to a population of 
cells. Because of the large number of decays necessary to give a significant dose when using 
low LET emitters like tritium, this average dose-rate is considered to be of relevance when 
describing the radio-biologic response of a cell population. 
 
The activity of the cell nucleus and the cytoplasm (difference between activity of whole cell 
and cell nucleus) was found experimentally using a liquid scintillation counter. The results 
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were used both to calculate the dose-rate from the model mentioned above and to plot the cell 
activity as a function of time to find when the incorporation was completed. 
 
2.3.2 THERMO LUMINESCENCE DOSIMETRY (TLD) 
TLD makes use of crystals with a trace amount of impurities, which have the ability to store a 
minute fraction of the absorbed energy in the crystal lattice. The absorbed radiation excites 
electrons or positive holes into metastable energy traps created by the presence of impurities 
for usefully long periods of time until deliberate heating releases the energy by emission of 
light photons.  
 
In order to avoid contributions from unstable low-energy traps, the crystals are preheated for 
10 minutes at 100 °C. The dose information is read by exciting the crystal with preheated 
nitrogen gas. The emitted light is measured by a photomultiplier tube which converts light into 
an electrical current. The current is then amplified and measured by a recorder. Finally the 
crystal is heated further to release any remaining energy from deeper traps. (Attix, 1986, 
Khan, 1994). 
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3 MATERIALS AND METHODS 
3.1 THE CELL LINES 
An established cell line is a cell population that has escaped senescence and divide 
indefinitely in culture. This “immortality” reflects the presence of genetic changes that have 
altered their proliferative properties (Alberts et al., 1994).  
 
Three cell lines were used, denoted T-47D, V 79, and NHIK 3025: 
 
The T-47D cell line was established in 1974 from the pleural effusion of a patient with breast 
carcinoma. The cells exhibit epithelial morphology and form monolayers in culture (Keydar et 
al. 1979). Immunohistologic studies and electron microscopy confirm the mammary epithelial 
origin. T-47D cells have normal RB function (2.1.2) (Åmellem et al., 1998; Stokke et al., 
1993), but contain only a single mutated p53 gene (Casey et al., 1991). Under normal 
favourable growth conditions, T-47D divide exponentially with a doubling time of 37.2±2.0 
hours (Stokke et al.; 1993). T-47D cells were routinely grown in the medium RPMI (Roswell 
Park Memorial Institute) 1640 with an addition of 10% foetal bovine serum, 1 % penicillin 
(5000 IU/ml), 1% streptomycin (5000 µg/ml), 1% L-glutamine and 0.2% insulin. RPMI 1640 
contains all the necessary nutrients, vitamins and inorganic salts, only fresh L-glutamine was 
added to the medium weekly because of its rapid decomposition. RPMI 1640 contains the pH 
indicator phenol red that changes colour from yellow to red when pH exceeds approximately 
7.4. 
 
 
V 79 cells originate from Chinese hamster embryonic lung fibroblasts and have a doubling 
time of 11±1 hours. P53 function is inactivated due to two point mutations in the DNA 
binding domain of p53. (Yu et al., 2000). V 79 cells were grown in MEM medium (Eagle’s 
Minimum Essential Medium) supplemented with 15% foetal calf serum, 2% 
penicillin/streptomycin, and 1% L-glutamine.  
 
NHIK 3025 cells were derived from cervical carcinoma in situ (Furre et al., 1999, Oftebro 
and Nordby 1969). This cell line express genes from the human papilloma virus 18 and the 
resulting oncoproteins E6 and E7 bind the proteins p53 and pRb obstructing their normal 
function. NHIK 3025 cells were grown in MEM medium like V 79. The doubling time is 22 
hours (Furre et al., 1999). 
3.2 CELL CULTIVATION 
3.2.1 EQUIPMENT 
The cells used in these experiments were grown in the Biophysics Cell Laboratory at the 
Department of Physics, University of Oslo (UIO) and irradiated with 60Co--radiation at the 
Norwegian Radium Hospital (DNR). 
 
To ensure sterility, all work where the cells or solutions, which would come in contact with 
the cells, were exposed to air took place in a sterile LAF bench (LAF = Laminar Flow) that 
was disinfected with 70% ethanol before and after use. The LAF bench used at UIO was of 
the type VB 2040 from OAS. For experiments T7-T20 facilities at the Norwegian Radium 
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Hospital was used for seeding the cells after the priming dose and for medium change and 
flushing before the challenge dose. In experiments T7-T9 the laboratory at the Biophysics 
Department (at DNR) was used; the LAF bench was a Holten Lamin Air HV 2448. This 
laboratory did not have facilities for sterile flushing, so after infection in part of experiment 
T9, further work was postponed until a new laboratory under the auspices of SUFS (Centre for 
Education and Research in Radiation Oncology) adjoining the irradiation room was finished. 
Experiments T10–T23 and N1-N3 were performed here in a LAF bench from Odd A. 
Simonsen A/S, Oslo. 
 
Only sterile equipment was used when working with the cells. Apart from polystyrene sterile 
pipettes (Bibby Sterilin Ltd, England) that were disposed of after use, all equipment was 
washed and sterilized at the laboratory at UIO. After lying in soap water (Decon 90, Decon 
Laboratories Limited England) it was rinsed in de-ionized water. Glass- and metal equipment 
was wrapped in aluminium foil and sterilized in a Termaks oven (Termaks, Bergen Norway) 
for approximately 2 hours at 180 °C. Rubber equipment and sheets were wrapped in sealed 
autoclave paper bags and autoclaved (Webco) for 20 minutes at 120 °C. The glass equipment 
was also burnt before use in a gas- or ethanol flame. The trypsin and medium were prepared at 
the laboratory (UIO) and sterilized by filtration (Millex-GP50 Filter Units, 0.22 µm, Millipore 
AS, Ireland). The medium was kept incubated at 37 °C for two days and controlled for 
infection to ensure sterility. The cells used in the experiments were grown in 25 cm2 sterile 
plastic culture flasks (Nunclon, Denmark) and were incubated in a semi-sterile CO2 incubator 
(UIO: National Heinicke Company, DNR, Biophysics department: Forma Scientific, USA, 
DNR, new laboratory: Thermo Forma, USA) with the lids unscrewed at 37 °C, 95% humidity 
and 5 % CO2. 
3.2.2 MAINTENANCE OF THE CELL LINE 
In order to ensure continuous proliferation, the cells need frequent fresh supplies of nutrients 
and growth factors and to be relieved of their own toxic waste. It is also important to control 
the cell density since both too high and too low density can repress cell growth. The cells were 
kept in exponential growth by recultivation twice a week, Monday and Friday and change of 
medium every Wednesday. 
 
Trypsin is a proteolytic enzyme that breaks the protein bonds between the cells and the surface 
they are attached to, and between neighbouring cells. The trypsin used for T-47D cells were 
added 0.2 mg/ml EDTA that bind the Ca2+ on which cell-cell adhesion depends (Alberts et al., 
1994) and thereby enhances the effect. V 79 and NHIK 3025 cells are more fragile and require 
a more gentle treatment than T-47D cells; here was used trypsin puck without EDTA. 
 
At recultivation the old medium was first removed, whereupon the cells were washed with 
trypsin (once for T-47D, twice for V 79 and NHIK 3025 cells) before new trypsin (3 ml in the 
25 cm2 flasks and 5 ml in the 80 cm2 flasks) was added. This was left until the cells had 
detached from the bottom and a Pasteur pipette was used to pump the suspension in order to 
separate the cells. The separation was examined in a microscope (Nikon TMS, Japan). The 
cell suspension was added to a test tube containing the same amount of medium as the amount 
of trypsin; this stopped the effect of the trypsin because of its reaction with the serum protein 
in the medium. The cells were centrifuged for 5 minutes at 1100 rpm and then resuspended 
into fresh medium, after the trypsin and medium had been discarded. A suitable amount of 
cells resulting in a favourable density was then added to flasks containing fresh medium (5ml 
for 25 cm2 flasks, 15 ml for 80 cm2 flasks) and flushed with 5% CO2 for a pH of ~7.4. The 
flasks were sealed before transfer to the incubator. 
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3.3 EXPERIMENTS 
T-47D cells need at least five hours to attach to the surface. In experiments T1-T6 the seeding 
took place the day before the irradiation at UIO. The next day the cells were flushed and 
sealed and transported in a preheated car enclosed in a thermos bag to DNR. Here the flasks 
were irradiated before being returned to UIO where the lids were unscrewed and the cells re-
incubated. The process of transport and irradiation took approximately 1 hour and 10 minutes. 
The experiments with V 79, V1-V6, followed the same routines except that they attach much 
more quickly and therefore were seeded the same day as the rest of the treatment was given.  
 
The cells that were given a priming dose were transported to DNR and irradiated with the 
priming dose in a 80 cm2 flask. After irradiation the cells were seeded at DNR following the 
procedures described below and incubated also at DNR until they were to receive the 
challenge dose. The medium was replaced with fresh flushed medium in order to discard of 
unattached cells, and the flasks were flushed and sealed before the challenge doses were given 
either 6 or 24 hours after the priming dose. In experiments T7–T9, where the laboratory at the 
Department for Biophysics (DNR)was used, the flasks were then transported to UIO for 
incubation. In T10–T22 and N1-N3, the cells were incubated at the new SUFS-laboratory, 
where they had also been seeded, for four to six days before they were taken back to UIO; the 
lids were sealed during transport. 
 
The cells in experiments T20-T22 and N1-N3 were seeded early in the morning at DNR and 
irradiated 6 and 4 hours later, respectively (NHIK 3025 attach in about two hours); the 
medium was exchanged and the flasks flushed with CO2 just before irradiation as in the 
priming dose experiments.  
3.3.1 SEEDING 
The cells used in experiments were trypsinized and centrifuged as described for recultivation. 
After resuspending the pellet into fresh medium, the cell suspension was diluted further before 
a sample was taken out to be counted in a Bürker chamber. The Bürker chamber consists of 
two chambers each with 3x3 squares. The number of cells was counted in 5 squares of each 
network, the highest and lowest values were discarded and the average from the 2 set 
calculated. The volume of each compartment with the cover glass put on was 10-4 ml; the 
number of cells per ml cell suspension was found by multiplying the average number with 
104. Appropriate dilutions were made and a specified number of cells depending on the 
irradiation dose to follow were seeded in 25 cm2 flasks (5 per dose) that were incubated in a 
CO2 incubator, the lids unscrewed. 
3.3.2 EXTERNAL IRRADIATION  
The irradiations took place at the Norwegian Radium Hospital with a cobalt source 
(Molbatron 80; TEM Instruments, Sussex, England). The cobalt source was installed in 1996 
and the inverse dose-rate was measured (SSD = 80 cm and field = 10 cm × 10 cm) at 0.5 cm 
depth to be 31.350 s/Gy on September 15th 1996. The half-life of 60Co is 1925.1 days. The 
irradiation time for a particular dose was found from the inverse dose-rate corrected for the 
reduction in activity, field size and depth. 
 
When irradiated with the highest dose-rate (HDR = acute irradiation) as well as with 0.9 Gy/h, 
the 5 flasks were placed on a 2 cm plate of water equivalent material (Perspex) and irradiated 
from beneath (gantry at 180°) (figure 3.1 a). The SSD (source-surface distance) used was 80 
cm and the field size 25 cm x 25 cm. For HDR the time for the shutter to be open to give the 
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wanted dose was calculated from the monitor factor (s/Gy) (inverse dose-rate corrected for 
decay) which was multiplied with a field size factor (0.95) and depth dose factor (2 cm ~ 
1.097 Gy). The dose-rate for acute radiation was approximately 50 Gy/h (54.6 Gy/h in the first 
experiments falling to 47.3 Gy/h in the last ones). To obtain the dose-rate of 0.9 Gy/h, the 
source was shielded by a 2 cm thick plate of Roos metal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Irradiation set-up: a) For HDR irradiation and irradiation with 0.9 Gy/h, the 
duration of the exposure was so short that irradiation could be performed in room-
temperature. The cell flasks were placed on a 2 cm Perspex-plate that rested on wooden 
beams to get the right height. In order to obtain the dose-rate of 0.9 Gy/h, the source was 
shielded with a 2 cm thick plate of Roos metal. b) During exposure with dose rates of 0.32 and 
0.045 Gy/h the cell flasks were submerged in a water tank that held 37 °C. The source was 
shielded with blocks of Roos metal.  
 
In order to obtain the lowest dose-rates used for priming, the source was shielded by blocks of 
Roos metal (Sn 25%, Pb 25%, Bi 50%, melting point 96 °C, specific weight 9.85 g/cm3). The 
thickness was 10cm for the dose-rate 0.32 Gy/h and 13cm for the dose-rate 0.045 Gy/h. In 
addition 1.6 cm brass was used to obtain the dose-rate 0.045 Gy/h. Because of the long 
irradiation time the flask was sealed within a plastic bag and submerged in an open water bath 
of Perspex (42 × 35 cm2, height 20 cm) maintained at a temperature of 37 °C by the use of a 
temperature-controlled heater (Tecne Temlette TE-8D, Princeton, NJ, USA) that also kept the 
water circulating. A lead block was put on top to keep the bottle from floating and ensure the 
right placement in the field (figure 3.1 b).  
DOSIMETRY 
The dose-rates for the shielded cobalt source were measured by Thorbjørn Furre using 
thermoluminescence dosimetry. Ribbons (3.2 × 3.2 × 0.9 mm3) made of LiF (TLD-100; 
Harshaw TLD Bicrom, Solon, OH, USA) were put in flasks containing 5 ml of absolute 
alcohol and irradiated in the set-up concerned. The readout process of the ribbons and the dose 
calculations followed the procedures standard at DNR. 
a) b) 
 20 
3.3.3 TRITIUM IRRADIATION 
The priming dose in experiments T 12, T 17 and T 19 was obtained from incorporated tritium. 
The tritium isotope 3H was incorporated in the proteins in the cells using the amino acid 
Valine as a specific marked precursor. Valine is one of the essential amino acid for humans 
and is a required component in the growth medium given to human cells in culture. Tritiated 
valine (TRK533, 1.0 mCi/ml, Amersham England) was added to the medium in a 
concentration corresponding to a specific activity of 1.6 Ci/mol (5.9×1010 Bq/mol). The 
specific activity was kept at a constant level by use of a high concentration of valine, 1.0 mM, 
in the medium. 
 
The cells were grown in medium with tritiated valine for four or five months. Six to seven 
hours before irradiation with the cobalt source, they were plated in medium with cold valine 
(no tritium), which was also used in all the following exchanges of medium. The cells were 
then irradiated according to the same challenge dose regime as were the other experiments 
involving priming doses.  
3.3.4 INCUBATION AND FIXATION 
The cells were incubated for a certain period depending on cell line and dose size (10-14 days 
for V 79 and NHIK 3025, 2–3 weeks for T-47D) and during this time medium was changed 
every 4–7 days. When the cell colonies were macroscopically visible, the cells were fixed. 
First the flasks were washed twice with medium or PBS (phosphate-buffered saline) to 
remove excess proteins. Then 2.5 ml ethanol was added and left for 3 minutes in order to fix 
the cells. Finally the cells were stained with 2.5 ml methylene blue for another 3 minutes 
before being gently de-stained by rinsing with water and left to dry. 
 
3.4 CALCULATION OF CELL SURVIVAL 
3.4.1 SURVIVING FRACTION  
The cell colonies were counted using a counter with a simple magnifier (Gerber Instruments, 
Germany). Only colonies consisting of more than 40 cells were scored as survivors. In cases 
of doubt, a microscope (Nikon TMS, Japan) was consulted. 
 
Each dose of radiation was given to five flasks. In addition five flasks were seeded as an 
unirradiated control group to measure the plating efficiency (PE), which is found as the 
fraction of cells seeded that grow into colonies: 
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where N(C) is the mean number of colonies in the control flasks and N0(C) is the number of 
cells seeded per flask in this group. 
The surviving fraction for each set of five flasks given the same treatment is given by: 
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N(B) is the mean number of counted colonies in the five flasks given treatment B and N0(B) is 
the number of cells seeded in each of the five flasks receiving treatment B. 
The standard error of the calculation of the mean value for each set of five flasks is given as: 
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The survival fraction SF(B) is a function of two variables N(B) and N0(B) (equation 3.2) and 
the standard error of the surviving fraction is given as: 
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3.4.2 CORRECTION FOR MULTIPLICITY 
Not all the cells were seeded as single cells. This is because complete cell separation would 
take so much time that trypsinization might harm the cells. In addition some cells will divide 
during the time between seeding and irradiation. This was particularly evident in the cases of 
24 hours between priming- and challenge dose. Multi-cell units would imply an enhanced 
probability of colony formation compared to single cells, since all cells in a unit would have to 
be inactivated to prevent the colony from being formed. In order to make corrections for this 
multiplicity, extra flasks were always seeded to be fixed at the time of each irradiation. These 
flasks were studied under microscope and all singlets, doublets, triplets etc. were counted. The 
multiplicity M was calculated as the mean number of cells per colony-forming unit: 
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 (3.5) 
where xi is the fraction of cell units consisting of  i cells. 
 
The actual fraction of surviving cells is f and the probability of a cell not forming a colony is 
(1-f). The probability of a cell unit of m cells not forming a colony is (1-f)m which means that 
the observed survival probability for one cell unit of m cells F will be: 
 
 F = 1-(1-f)m (3.6) 
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For a population of multi cell units containing 1 to m cells the surviving fraction SF is given 
by: 
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 (3.7) 
Had there been only singlets and doublets the corrections would be as follows:   
  
 M = x1+2x2 (3.8) 
 
Where x1+x2 = 1  
x1 and x2 are found from these equations and inserted into equation (3.7) which is solved for f, 
the actual surviving fraction, giving it as a function of the observed surviving fraction SF and 
the mean multiplicity M (= mean number of cells per colony forming unit): 
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In the present experiments the multi cell units were not restricted to singlets and doublets. In 
order to calculate the exact correction for multiplicity one would end up with very 
complicated expressions for f. As an approximation, f was found from equation (3.9) using M 
from equation (3.5). The deviations from the exact solution using this approximation was 
calculated for cell units containing up to three cells by Heidi Lorentzen (Lorentzen, 2001) and 
found to be less than 1 %.  
 
To find a value for the uncertainty of M, denoted ∆M, some of the flasks were counted several 
times, since both the specific part of the surface chosen (as the cell distribution will never be 
homogeneous) as well as human interpretations of what is actually seen influence on the 
result. ∆M was found to be 0.03. 
 
The standard error of f is a function of ∆M and S.E.(SF) (=∆SF in the following): 
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3.4.3 THE MEAN VALUE OF SURVIVING FRACTIONS 
In the repeated experiments the mean survival fraction, fm, was found weighting the number of 
flaks in each experiment, ni: 
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where k is the number of experiments. 
Since the calculations of error in each experiment were encumbered with uncertainties, the 
standard error was used for the mean survival fraction: 
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3.4.4 PRESENTATION OF SURVIVAL DATA 
The survival curves present the surviving fractions as a function of dose in a semi-logarithmic 
plot. The plots of the data from each experiment are included in appendix D together with the 
raw data and plots of mean values of surviving fraction from parallel experiments as a 
function of dose are shown in appendix E.  
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The survival curve fits presented in chapter 4 represent curve fittings done by Hans Kristian 
Opstad using IDL curve fit. The data were fitted by either the linear-quadratic model (LQ-
model) or the induced repair model (IR-model) using the method of least–squares and 
weighting the errors. The details of this will be presented in the cand. Scient. thesis by Opstad. 
 
The standard error for the mean survival of the control flasks is implicit in the errors for the 
other survival data through the error in the plating efficiency. Therefore, the survival of 1 at 
dose zero is plotted without error-bars in all dose-response curves. 
 
The averaged data points are also replotted in the form of effect per unit dose. In this type of 
plot, a LQ response will follow a straight line with a y-intercept equal to  and a slope equal to 
: 
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 (4.1) 
 
In the limit of D0, -(lnS)/D approaches . 
In the IR-model (equation 2.7)  is replaced with: 
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For doses much larger than Dc this  approaches r with increasing doses. In the limit of 
D0,  approaches s, which means that the y-intercept from a back-extrapolation of the low 
dose data equals to s. 
 
 
3.5 FLOW CYTOMETRY 
Flow cytometry is a quantitative method for analysis and separation of cells in suspension. A 
fluorescent dye is attached to a specific component of the cells or cell nuclei and the cells in 
the suspension are led to flow, one at a time, through one or more laser-beams. The laser beam 
induces a fluorescence pulse whose intensity represents the quantity of the cellular component 
in question. The forward light scatter depends on the cell size and the side scatter reflects the 
morphology of the cell. The flow cytometry was performed by Pål Graff and is used in this 
study to find the distribution of cells in the various phases of the cell cycle; the relative cell 
number was plotted against the relative DNA content in a DNA histogram.  
 
The cells were trypsinized and washed once with PBS, fixed in 70% methanol, and stored at   
-20 ºC. The subsequent steps were done at 0 ºC. The cells were washed three times in PBS 
prior to the DNA staining with 2 g ml-1 Hoechst 22158. 
Stained cells were measured in a FACStarPLUS flow cytometer (Becton Dickinson) equipped 
with one argon and one krypton laser (Spectra Physics) tuned to 48 nm and UV, respectively. 
Forward light scatter (FSC) and side scatter (SSC) were measured. The data were gated on 
FSC versus SSC and Hoechst 33258-flourescence pulse area versus pulse width to exclude 
dead cells and aggregates of cells, respectively (not shown in the figures). 
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4 RESULTS 
4.1 ACUTE IRRADIATION OF THREE CELL LINES  
Cell survival experiments were conducted with three different cell lines of which two, T-47D 
and V79, were found to express hyper-radio-sensitivity (HRS) in the low dose region. The 
survival curves are shown in figure 4.1. Values for the parameters from the fittings of the LQ-
model and the IR-model, respectively, are given in table 1 and 2 along with their associated 
errors.  
 
For T-47D and V79 data cells from six experiments were used, three and three preponderant 
in the high or low dose region, respectively (experiments T1-T6 and V1-V6), and there is no 
doubt that the IR-model makes the best fit to data in the low-dose range from both cell lines. 
The survival curves for T-47D and V79 cells are almost coincident for doses larger than 2 Gy 
but the T-47D curve has a much more pronounced HRS at small doses.  
 
The averaged data points from figure 4.1 are also replotted in figure 4.2 in the form of effect 
per unit dose (see chapter 3.4.4). In this type of plot, a LQ response (equation 2.6) will follow 
a straight line with a y-intercept equal to  and a slope equal to . 
 
Table 3 summarizes the values of the  and  values from linear regression to a selection of 
the data that fits the LQ-model. The transition from the hypersensitive to the more 
radioresistant response varies somewhat in the two cell lines. The fit of the LQ-model was 
done to data from 1 Gy and up for T-47D cells but from 0.75Gy and up for V79 cells. 
NHIK 3025 cells were irradiated with doses up to 5 Gy with emphasis on the low doses 
(experiments N1-N3). For NHIK 3025 cells, the LQ-model seemed to make the best fit and it 
was not possible to detect any signs of HRS (figure 4.2c and figure 4.1). These cells had a 
much lower survival for doses larger than 2 Gy than cells of the other two cell lines (two 
decades at 10 Gy). 
 
 
 
 
 
 
 
 
 
 
Cell line 
  
(Gy-1)  (Gy-2)  /  (Gy) 
T-47D 0.186 ± 0.010 0.0129 ± 0.0012 14.4 ± 1.5 
NHIK 3025 0.125 ± 0.019 0.064 ± 0.004 1.88 ± 0.33 
V79 0.137 ± 0.006 0.0182 ± 0.0006 7.53 ± 0.41 
Table 1: Values of the parameters from the best curve fit of the LQ-model to the experimental 
data. For T-47D and V79 cells the fitting was done only to data from doses above the 
HRS/IRR range and the data points were weighted according to standard error in each 
experiment. 
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Figure 4.1: Surviving fraction as a function of dose for T-47D cells (∆), V79 cells (), and 
NHIK 3025 cells (). Data points represent mean values from three independent experiments 
and vertical bars represent standard errors. The curves represent model fits to the data and 
the data points were weighted according to standard error in each experiment: The IR-model 
was fitted to the data for T-47D (experiments T1-T6) and V79 (experiments V1-V6) cells. Data 
for NHIK 3025 cells (experiments N1-N3) were fitted by the LQ-model, the values of  and  
used were found from linear regression in the effect-per-unit-dose plot (figure 4.2 c). a): All 
data included. b): Only data up to 2 Gy included. 
 
 
 
 
 
 
 
Cell line 
 s (Gy-1)  r (Gy-1)   (Gy-2)  / (Gy) Dc (cGy) 
T-47D 2.19 ± 0.54 0.168 ± 0.011 0.0149 ± 0.0013 11.3 ± 1.2 36 ± 6 
V79 0.58 ± 0.21 0.137 ± 0.002 0.0182 ± 0.0002 7.43 ± 0.14 16 ± 5 
Table 2: Values of the parameters from the best curve fit of the IR-model to the experimental 
data. The data points were weighted according to standard error in each experiment. 
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Figure 4.2: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
and  was found by linear regression of the 
LQ-model to data (solid lines) for doses 
larger than a) 1 Gy for T-47D cells b) 0.75 
Gy for V79 c) 0.5 Gy for NHIK 3025. 
 
 
 
 
 
 
 
 
Cell line 
  
(Gy-1)  (Gy-2) 
T-47D 0.172 ± 0.166 0.0148 ± 0.0333 
NHIK 3025 0.0606 ± 0.0094 0.0701 ± 0.0807 
V79 0.0969 ± 0.0668  0.0209 ± 0.0194  
Table 3: Values of the parameters found by linear regression of the LQ-model to data points 
in the effect-per-unit-dose versus dose plots. The data points do not include the point (D=0, 
f=1) and are not weighted 
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4.2 ADAPTIVE RESPONSE IN T-47D CELLS 
In all the experiments with acute irradiation subsequent to a priming exposure, the cells 
responded with a reduction of the HRS. In the fits of the IR-model to the data fixed values of 
the parameters 
 r, , and Dc was used, which were obtained from the fits to the data from 
experiments without a priming dose (table 2). It was assumed that these parameters were 
characteristic of the cell line as the irradiation setup was kept the same.  
 
Figure 4.3 and figure 4.4 show the survival curves for T-47D cells given an acute priming 
dose of 0.3 Gy (experiments T7 and T8) 6 hours and 24 hours prior to the challenge dose, 
respectively. Six hours after the priming exposure the HRS was diminished as compared to 
that observed after one acute dose (figure 4.3) and 24 hours after the priming exposure HRS 
was only partially restored (figure 4.4). The radiation response six hours after a low dose-rate 
priming dose (0.9 Gy/h) was similar to that following a high dose-rate priming dose (figure 
4.6). The data 24 hours after priming are missing because of an infection.  
 
 
 
Figure 4.3: Surviving fraction as a function of dose. Data points represent single observations 
of two independent experiments for T-47D cells given a HDR priming dose of 0.3 Gy 6 hours 
prior to the challenge doses and vertical bars represent standard errors. The curves represent 
model fits to the data: The IR-model was fitted to the data points shown (solid line). Also shown 
are the fit of the LQ-model (dotted line) and the IR-model (dashed line) to data from unprimed 
T-47D cells. a): All data included. b): Only data up to 2 Gy included. 
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Figure 4.4: Surviving fraction as a function of dose. Data points represent single observations 
of two independent experiments for T-47D cells given a HDR priming dose of 0.3 Gy 24 hours 
prior to the challenge doses and vertical bars represent standard errors. The curves represent 
model fits to the data: The IR-model was fitted to the data points shown (solid line). Also shown 
are the fit of the LQ-model (dotted line) and the IR-model (dashed line) to data from unprimed 
T-47D cells. a): All data included. b): Only data up to 2 Gy included. 
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Figure 4.5: Effect per unit dose. -(lnS)/D =  + D is plotted as a function of dose. T-47D 
cells were pre-exposed to a HDR priming dose of 0.3 Gy. The solid line represents linear 
regression to data for unprimed T-47D cells (figure 4.2 a). The interval between priming dose 
and challenge dose were either a) 6 hours or b) 24 hours. 
 
 
 
 
 
 
 
 
Figure 4.5 and figure 4.7 show the effect-per-unit-dose as a function of dose. The solid line 
represents the best fit of the LQ-model to the data for T-47D cells without priming from figure 
4.2a. It is seen to fit the data quite well, which is also the case relative to the survival curves 
fitted by the LQ-model to data from unprimed cells (dotted line) as seen in figures 4.3, 4.4, 
and 4.6, and this justifies the practice of using the fixed values of  and  in the fittings. 
 
The 
 s and  s/r values from the IR-fits are shown in table 4. The degree of HRS relative to a 
back-extrapolation of the LQ-curve is reflected in the size of 
 s/r.  s/r dropped from 13.1 
without priming to 5.4 (4.2 in experiment T9 with priming dose-rate 0.9 Gy/h) six hours after 
a priming dose of 0.3 Gy. After another 18 hours following the priming dose the 
 s/r had 
increased to 8.3 which is approaching, but still significantly lower than, the 13.1 for the 
unprimed cells. 
 
In two experiments the cells that were used had been pre-irradiated by incorporated tritium for 
several months at a dose-rate to the cell nucleus of 0.01 Gy/h. The total dose received by this 
low-dose pre-irradiation at the time of the two acute irradiation experiments was 24.7 Gy and 
36.2 Gy, respectively. The survival curve of the subsequent acute irradiation is shown in 
figure 4.8. The HRS is totally absent and the data are best fitted by the LQ-model. Figure 4.9 
shows the effect per unit dose. The solid line represents the best fit of the LQ-model to the 
data for T-47D without priming from figure 4.2 a.  
 
 
 
T-47D, HDR priming, 6 hours
Dose (Gy)
0 1 2 3 4 5
-
(ln
S)
/D
0
1
2
3
4
T-47D, HDR priming, 6 h
regression to T-47D
T-47D, HDR priming, 24 hours
Dose (Gy)
0 1 2 3 4 5
-
(ln
S)
/D
0
1
2
3
4
T-47D, HDR priming, 24h
regression to T-47Da) b) 
 31 
 
 
 
Figure 4.6: Surviving fraction as a function of dose. Data points represent one experiment for 
T-47D cells given a 0.3 Gy priming dose with dose-rate 0.9 Gy/h prior to the challenge doses 
and vertical bars represent standard errors. The curves represent model fits to the data: The 
IR-model was fitted to the data points shown (solid line). Also shown are the fit of the LQ-
model (dotted line) and the IR-model (dashed line) to data from unprimed T-47D cells. a): All 
data included. b): Only data up to 2 Gy included. 
 
 
 
 
 
 
 
 
Figure 4.7: Effect per unit dose. -(lnS)/D =  
+ D is plotted as a function of dose. T-47D 
cells were pre- exposed to a priming dose of 
0.3 Gy given with 0.9 Gy/h 6 hours before 
challenge dose. The solid line represents 
linear regression to data for unprimed T-47D 
cells (figure 4.2 a). 
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Figure 4.8: Surviving fraction as a function of 
dose. Data points represent single 
observations of two independent experiments 
for T-47D cells pre-irradiated by incorporated 
tritium for several months at a dose-rate to the 
nucleus of 0.01 Gy/h. The curves represent 
model fits to the data: The IR-model was fitted 
to the data points shown (solid line). Also 
shown are the fit of the LQ-model (dotted line) 
and the IR-model (dashed line) to data from 
unprimed T-47D cells.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Effect per unit dose. 
 -(lnS)/D =  + D is plotted as a 
function of dose. T-47D cells were pre-
irradiated by incorporated tritium for 
several months at a dose-rate to the 
nucleus of 0.01 Gy/h. The solid line 
represents linear regression to data for 
unprimed T-47D cells (figure 4.2 a). 
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Priming dose 
(Gy) 
Priming dose-
rate (Gy/h) 
Time between 
priming and 
challenge doses (h) 

 s (Gy-1) 
 s/r 
0.3 HDR 6 0.9 ± 0.2 5.4 ± 1.2 
0.3 HDR 24 1.4 ± 0.4 8.3 ± 2.4 
0.3 0.9 6 0.7 ± 0.5 4.2 ± 3.0 
~30 0.01 0 (-0.03 ± 0.3)  
none   2.2 ± 0.5 13.1 ± 3.1 
 
Table 4: 
 s and  s/r -values from the fits to the IR-model of data from experiments with T-
47D cells. The size of the 
 s/r-values reflects the degree of HRS. 
 
 
4.3 FLOW CYTOMETRY DATA 
A DNA histogram normally has two peaks, one for cells with DNA content corresponding to 
G1- phase and the second for cells with the double amount of DNA corresponding to G2- and 
M-phase. In between the two peaks, cells in the S-phase are registered. The areas of the peaks 
reflect the number of cells in the particular phases. As the duration of the G1-phase is 
generally considerably longer than G2- and M-phase, the first peak (normalized to channel 
200) is much larger than the second peak. T-47D cells spend 23.6±2.9 hours in G1 and the full 
cell cycle lasts 37.2±2.0 hours (Stokke et al., 1993). These numbers are well in line with the 
DNA histogram shown in figure 4.10 a, of T-47D cells prepared in May 2002. However, when 
a DNA histogram was made of the T-47D cells in December 2002, a change from the usual 
pattern was discovered (figure 4.10 b). This DNA histogram indicates that our cell line at that 
time contained two different stem lines with different DNA content. The indications that there 
could be a mix of cells were confirmed after repeated investigations in January 2003. In 
addition to the normal spectrum, the histogram in figure 4.10 b shows a large peak close to 
channel 400 and a smaller one with twice the DNA content. Although such a histogram is 
usually taken to indicate the presence of another cell line, one can not exclude that there is a 
population of T-47D cells that for some reason has an altered DNA-ploidy. 
 
We wanted to test whether we could have had a mix-in from another cell line cultured in our 
laboratory. Of the cell lines present in the laboratory, The T-47D cells adapted to hydroxyurea 
(HU) and MCF-7 were quickly ruled out as candidates (data shown in appendix F). The 
remaining possibility was NHIK 3025 cells. The DNA histogram of cells of this cell line is 
shown in figure 4.10 c. A comparison of panel b and c in figure 4.10 shows a convincing 
agreement between DNA histograms of the mixed cells and NHIK 3025 cells. 
 
The experiment in which cells with incorporated tritium were irradiated was initiated at a time 
where the cells could have been of the T-47Dmix-type. The similarity between the DNA 
histograms of the control group (figure 4.11 a) and of T-47Dmix (figure 4.10 b) confirm that 
this was the case. The DNA histogram of the irradiated cells (figure 4.11 b) was on the other 
hand in exact agreement with the one of pure T-47D cells (figure 4.10 a). 
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Figure 4.10: DNA histograms. The relative cell number is plotted against the relative DNA 
content given as channel numbers of the multichannel analyzer used. a): DNA histogram of T-
47D cells (May 2002). The first peak contains the cells with a DNA amount corresponding to 
G1-phase and the second the cells with twice the amount corresponding to G2- and M-phase. 
In between the S-phase cells are registered. b): The DNA histogram for T-47D cells prepared 
December 2002 shows a mixture of two stem lines having different DNA content (T-47Dmix). c) 
DNA histogram of NHIK 3025 cells. 
Note that in panels a and b the ordinate axes are placed at channel number 80, while in panel 
c it is placed at channel number 0.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 DNA histograms. The relative cell number is plotted against the relative DNA 
content given as channel numbers of the multichannel analyzer used.  a): The unirradiated 
cells from the experiment with incorporated tritium. b): Cells irradiated by incorporated 
tritium for several month at a dose-rate to the cell nucleus of 0.01 Gy/h. Both these cell types 
were cultured in a medium containing 1 mM valine, which is a higher concentration than in 
usual RPMI medium. 
(a) G1 
 
(a) (b) 
G2 & M 
(b) 
c) 
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4.4 SURVIVAL CURVES OF THE MIXED CELL POPULATION 
The effect-per-unit-dose as a function of dose plot for the T-47Dmix cells (i.e. the T-47D cells 
with an extra unknown stem line) (experiments T20-T22) is shown in figure 4.14. A fit of the 
LQ-model was done to the data from 2Gy and up by linear regression. The  and  values 
determined from figure 4.14 (table 5) was used in the fitting of the IR-model shown in the 
survival curve in figure 4.12 (dashed line with double dots), which was only done to data 
below 1 Gy simply in order to make the best fitting to the data. The dose response of a mixed 
population can probably not be expected to be described by the standard models, so certain 
variations were tried as to which parameters to fix and which data to weight in all the fittings 
to data from this cell population. Even then it is seen from the resultant survival curves 
(figures 4.12, 4.15, 4.17, 4.19, 4.21, 4.23, and 4.25) that the IR-model in most cases does not 
make convincing fittings to the data. 
 
Figure 4.13 shows the mean surviving fraction data in addition to the respective curve fits by 
the IR-model for T-47D (dotted line) and T-47Dmix cells (dashed line with double dots) and by 
the LQ-model for NHIK 3025 cells (solid line). Values of the parameters of the fit to data for 
T-47Dmix cells are shown in table 5. The T-47Dmix cells seem to be more sensitive to doses 
larger than 5 Gy than pure T-47D cells although they still have a higher survival than the 
NHIK 3025 cells. At doses less than 1 Gy the T-47Dmix cells show HRS in contrast to the 
NHIK 3025 cells, though somewhat less than for the pure T-47D cells. Figure 4.12 and figure 
4.13 also include a theoretically calculated curve for a mixed population of T-47D and NHIK 
3025 cells, respectively (dashed line). The weighting of the NHIK 3025 parameters was 
chosen to be 55 % from an estimation of the areas of the peaks in the DNA histogram for T-
47Dmix (figure 4.10 b). In figure 4.12 it is seen that the calculated curve of this theoretical mix 
makes a possible fit though not the best one to the T-47Dmix data. The fitting of the T-47Dmix 
data as well as the calculated curve of the theoretical mixed population of T-47D and NHIK 
3025 cells is seen to lie above the averaged data points in the hypersensitive dose range and in 
this dose region the cells seem to respond much more like T-47D than NHIK 3025 cells. In 
the high dose range the T-47Dmix survival data show lower survival than both T-47D cells and 
the calculated curve for the theoretically mixed population of T-47D and NHIK 3025 cells 
predicts, and in this dose range the response is closer to that of NHIK 3025 cells. 
 
 
 
 
 
 
 
 
 
r (Gy-1)  (Gy-2) / (Gy) s (Gy-1) Dc (Gy) s/r 
0.0989 ± 0.2375 0.0337 ± 0.0491 2.9  1.08 ± 0.39 45 ± 13 10.9  
 
Table 5: Values of parameters from two different fittings. r and  are found from linear 
regression by the LQ-model to T-47Dmix data as plotted in the effect per unit dose-plot (figure 
4.14) and s and Dc are parameters of the fit by the IR-model to T-47Dmix data as plotted in 
the survival curve (figure 4.12).  
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Figure 4.12: Surviving fraction as a function of dose. Data points of T-47Dmix cells represent 
single observations of three independent experiments and vertical bars represent standard 
errors. The curves represent model fits to the data: The IR-model was fitted to the data points 
below 1 Gy with fixed values of r and  obtained from the fit done to the data in the effect-
per-unit-dose plot (figure 4.14) (dashed line with double dots). Also shown are the fit of the 
IR-model to data for T-47D cells (dotted line) and the LQ-model to data for NHIK 3025 cells 
along with the calculated curve for the theoretically mixed population of 55 % NHIK 3025 
and 45 % T-47D cells. a): All data included. b): Only data up to 2 Gy included. 
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Figure 4.13: Surviving fraction as a function of dose for NHIK 3025 cells (), T-47D cells 
(),  and T-47Dmix cells (). Data points represent mean values of three independent 
experiments and vertical bars represent standard errors. The curves represent model fits to 
the data: The IR-model was fitted to the data for T-47Dmix cells (dashed line with double dots) 
and to data for T-47D cells (dotted line) and the LQ-model to data for NHIK 3025 cells. Also 
shown is the calculated curve for the theoretically mixed population of 55 % NHIK 3025 and 
45 % T-47D cells. a): All data included. b): Only data up to 2 Gy included. 
 
 
 
 
 
 
 
 
Figure 4.14: Effect per unit dose. -(lnS)/D 
=  + D is plotted as a function of dose.  
and  was found by linear regression of the 
LQ-model to data for T-47Dmix cells (solid 
lines) for doses larger than 2 Gy. 
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4.5 ADAPTIVE RESPONSE IN THE MIXED CELL POPULATION 
The cells used in the experiments with the priming dose given with low dose-rates turned out 
to be of the mixed cell population. Also one of the experiments with HDR priming happened 
to be with T-47Dmix cells. In all the fittings used the  and  values from the unprimed T-
47Dmix (table 4) were used and the fitting of the IR –model was done to the complete data sets 
except for the experiment with HDR priming 6 hours before the challenge dose, where only 
data for doses below 1 Gy was used in order to obtain a satisfying fit (figure 4.15 and figure 
4.17). Since the HDR priming was done in only one single experiment the interpretation of 
figure 4.15 and 4.17 and the effect-per-unit-dose versus dose plots (figure 4.16 and figure 
4.18) is far from conclusive. There is no doubt that the HRS has vanished 6 hours after 
priming and there is a tendency of recovery 24 hours after priming but not nearly as strong as 
for the pure T-47D cells. Six experiments were done with low-dose-rate (LDR) priming (using 
a priming dose of 0.3 Gy) with dose-rates of 0.32 Gy/h (figure 4.19 and figure 4.21) or 0.045 
Gy/h (figure 4.23 and figure 4.25). Even these LDR priming doses was seen to reduce HRS 6 
hours after the priming dose (figure 4.19 and figure 4.23). When the dose-rate of the priming 
dose was 0.32 Gy/h, the HRS had totally vanished after 24 hours (figure 4.21), and also with 
dose-rate 0.045 Gy/h there is little left if any (figure 4.25). The effect-per-unit-dose versus 
dose plot for the experiment with the dose-rate of 0.32 Gy/h of the priming dose is shown in 
figure 4.20 and figure 4.22. It is seen that the  and  values from the unprimed T-47Dmix 
fitting (figure 4.11) make convincing fits to most data points of all experiments with primed 
cell as they would in absence of HRS (figures 4.16, 4.18, 4.20, 4.22, 4.24, and 4.26). Values 
of 
 s,  s/r, and Dc are given in table 6, but since it is questionable to use the IR-model in the 
case of a mixed population of cells, these values may contain systematic uncertainties. 
 
Because of the problems with applying the IR-model to the data of the mixed population of 
cells, the plots of surviving fraction versus dose without any fittings are shown for 
experiments with T-47Dmix cells given a priming dose of 0.3 Gy with the low dose-rates 
(figure 4.27). The same trends as mentioned above are seen and in these plots they appear 
more convincing. 
 
 
 
Priming 
dose (Gy) 
Priming dose-
rate (Gy/h) 
Time between 
priming and 
challenge doses (h) 

 s (Gy-1) Dc (Gy) 
 s /  r 
0.3 HDR 6 -36 ± 52 0.027 ± 0.010  
0.3 HDR 24 0.52 ± 1.72
 
0.16 ± 80 5.3 
0.3 0.32 6 0.310 ± 0.079
 
0.73 ± 0.24 3.1 
0.3 0.32 24 0.23 ± 2.30 0.18 ± 0.94 2.3 
0.3 0.045 6 0.32 ± 0.16 0.63 ± 0.44 3.2 
0.3 0.045 24 0.32 ± 0.20 0.50 ± 0.26 3.2 
None   1.09 ± 0.38 0.45 ± 0.13 11.0 
Table 6: 
 s and  s/r -values from the fits to the IR-model of data from experiments with T-
47Dmix cells. The size of the  s/r-values reflects the degree of HRS. 
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Figure 4.15: Surviving fraction as a function of dose. Data points represent one experiment for 
T-47Dmix cells given a HDR priming dose of 0.3 Gy 6 hours prior to the challenge doses and 
vertical bars represent standard errors. The curves represent model fits to the data: The IR-
model was fitted to the data points shown (solid line). Also shown are the fit of the LQ-model 
(dotted line) and the IR-model (dashed line) to data from unprimed T-47Dmix cells. a): All data 
included. b): Only data up to 2 Gy included. 
 
 
 
 
 
 
 
 
 
Figure 4.16: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
T-47Dmix cells were exposed to a HDR 
priming dose of 0.3 Gy. The solid line 
represents linear regression to data for 
unprimed T-47Dmix cells (figure 4.14). The 
interval between priming dose and challenge 
dose was 6 hours. 
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Figure 4.17: Surviving fraction as a function of dose. Data points represent one experiment for 
T-47Dmix cells given a HDR priming dose of 0.3 Gy 24 hours prior to the challenge doses and 
vertical bars represent standard errors. The curves represent model fits to the data: The IR-
model was fitted to the data points shown (solid line). Also shown are the fit of the LQ-model 
(dotted line) and the IR-model (dashed line) to data from unprimed T-47Dmix cells. a): All data 
included. b): Only data up to 2 Gy included. 
 
 
 
 
 
 
 
 
Figure 4.18: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
T-47Dmix cells were exposed to a HDR 
priming dose of 0.3 Gy. The solid line 
represents linear regression to data for 
unprimed T-47Dmix cells (figure 4.14). The 
interval between priming dose and 
challenge dose was 24 hours. 
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Figure 4.19: Surviving fraction as a function of dose. Data points represent single 
observations of three experiments for T-47Dmix cells given a priming dose of 0.3 Gy with dose-
rate 0.32 Gy/h 6 hours prior to the challenge doses and vertical bars represent standard 
errors. The curves represent model fits to the data: The IR-model was fitted to the data points 
shown (solid line). Also shown are the fit of the LQ-model (dotted line) and the IR-model 
(dashed line) to data from unprimed T-47Dmix cells. a): All data included. b): Only data up to 2 
Gy included. 
 
 
 
 
 
 
 
Figure 4.20: Effect per unit dose. -(lnS)/D =  
+ D is plotted as a function of dose.  
T-47Dmix cells were exposed to a priming dose 
of 0.3 Gy with dose-rate 0.32 Gy/h. The solid 
line represents linear regression to data for 
unprimed T-47Dmix cells (figure 4.14). The 
interval between priming dose and challenge 
dose was 6 hours. 
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Figure 4.21: Surviving fraction as a function of dose. Data points represent single 
observations of three experiments for T-47Dmix cells given a priming dose of 0.3 Gy with dose-
rate 0.32 Gy/h 24 hours prior to the challenge doses and vertical bars represent standard 
errors. The curves represent model fits to the data: The IR-model was fitted to the data points 
shown (solid line). Also shown are the fit of the LQ-model (dotted line) and the IR-model 
(dashed line) to data from unprimed T-47Dmix cells. a): All data included. b): Only data up to 2 
Gy included. 
 
 
 
 
 
 
 
 
Figure 4.22: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
T-47Dmix cells were exposed to a priming 
dose of 0.3 Gy with dose-rate 0.32 Gy/h. The 
solid line represents linear regression to data 
for unprimed T-47Dmix cells (figure 4.14). The 
interval between priming dose and challenge 
dose was 24 hours. 
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Figure 4.23: Surviving fraction as a function of dose. Data points represent single 
observations of three experiments for T-47Dmix cells given a priming dose of 0.3 Gy with dose-
rate 0.045 Gy/h 6 hours prior to the challenge doses and vertical bars represent standard 
errors. The curves represent model fits to the data: The IR-model was fitted to the data points 
shown (solid line). Also shown are the fit of the LQ-model (dotted line) and the IR-model 
(dashed line) to data from unprimed T-47Dmix cells. a): All data included. b): Only data up to 2 
Gy included. 
 
 
 
 
 
 
 
 
 
Figure 4.24: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
T-47Dmix cells were exposed to a priming 
dose of 0.3 Gy with dose-rate 0.045 Gy/h. 
The solid line represents linear regression 
to data for unprimed T-47Dmix cells (figure 
4.14). The interval between priming dose 
and challenge dose was 6 hours. 
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Figure 4.25: Surviving fraction as a function of dose. Data points represent single 
observations of three experiments for T-47Dmix cells given a priming dose of 0.3 Gy with dose-
rate 0.045 Gy/h 24 hours prior to the challenge doses and vertical bars represent standard 
errors. The curves represent model fits to the data: The IR-model was fitted to the data points 
shown (solid line). Also shown are the fit of the LQ-model (dotted line) and the IR-model 
(dashed line) to data from unprimed T-47Dmix cells. a): All data included. b): Only data up to 2 
Gy included. 
 
 
 
 
 
 
 
 
Figure 4.26: Effect per unit dose. -(lnS)/D = 
 + D is plotted as a function of dose.  
T-47Dmix cells were exposed to a priming 
dose of 0.3 Gy with dose-rate 0.045 Gy/h. The 
solid line represents linear regression to data 
for unprimed T-47Dmix cells (figure 4.14). The 
interval between priming dose and challenge 
dose was 24 hours. 
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Figure 4.27: Surviving fraction as a function of dose for T-47Dmix cells. Data points represent 
mean values of three independent experiments and vertical bars represent standard errors. In 
all plots data points of unprimed cell are marked with , data points of cells given the 
priming dose 6 hours before the challenge dose are marked with , and data points of cells 
given the priming dose 24 hours before the challenge dose are marked with . a): Dose-rate 
of priming dose is 0.32 Gy/h and all data are included. b): Dose-rate of priming dose is 0.32 
Gy/h and only data up to 2 Gy are included. c) Dose-rate of priming dose is 0.045 Gy/h and 
all data are included. d) Dose-rate of priming dose is 0.045 Gy/h and only data up to 2 Gy are 
included. 
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5 DISCUSSION 
5.1 RADIATION RESPONSE FOLLOWING ACUTE IRRADIATION  
Of the cell lines used in these experiments only V79 cells were known to express HRS as a 
response to low dose irradiation. The first experiments in this study (experiments T1-T6, acute 
irradiation of T-47D cells and experiments V1-V6, acute irradiation of V79 cells) not only 
revealed that T-47D cells do express HRS but also that it is much more pronounced than for  
V79 cells (figure 4.1). This is consistent, however, with a general tendency for cells of human 
lines, which do express HRS, relative to V79 cells, which are of Chinese hamster origin 
(Joiner et al., 2001). Later, cells of a third line NHIK 3025 of human origin were investigated, 
and in these cells no HRS was found; the cells of this cell line were also much more 
radiosensitive to high doses of radiation than those of the other two lines (figure 4.1). 
 
For V79 cells the survival curve of the present study is in concordance with those published 
by Joiner at al. (1996) within the whole dose range examined (table 8). Several other reports 
show lower cell survival for cells of various V79 sublines The results of Tsoulou et al. (2001) 
indicate a 4-5 times lower surviving fraction than that of the present study for 10 Gy, and also 
the survival found in the studies of Skwarchuk et al. (1993) and Skarsgard et al. (1993) were 
lower at 10 Gy than the value from the present study. For T-47D cells there is a clear HRS, 
which had not been detected in our previous studies since these did not include doses below 1 
Gy. In addition the T-47D cells used in the present study seemed to be more resistant to high 
radiation doses than those studied in experiments listed in table 7. At 10 Gy the present data 
indicated a survival 5 to 10 times higher than those of Hanish and Furre. Also the survival of 
NHIK 3025 cells was found to be higher in the present study than expected from previous 
studies. At 10 Gy the surviving fraction recorded in the present experiments was 5 times 
higher than in that of Furre et al. (1999) and 3 times higher than that of Pettersen and Wang 
(1996) for asynchronous NHIK 3025 cells.  
 
It seems that all the cell lines were more resistant to radiation in the present experiments as 
compared to most earlier investigations. The cells were irradiated with 60-cobalt -rays in the 
present and with x-rays in the other studies. The exception is the experiments performed by 
Tsoulou et al. (2001), but their experiments were performed with semi-confluent cells and can 
not be directly compared with those with exponentially growing cells. However, there is no 
particular reason to believe that the difference in radiation modality should account for the 
discrepancies.  
 
Tables 7, 8 and 9 give the / values from previous studies on cells of various cell lines along 
with the values from the present study. The values listed in table 7 (for T-47D cells) and tables 
9 (for NHIK 3025 cells) from the present study are from curve fittings based on the LQ model 
(figure 4.1 and table 1). As regards V79 cells, the values obtained from the LQ-fit (table 1)are 
in almost perfect agreement with the ones found using the IR-model (table 2), whereas the 
values obtained from the effect-per-unit-dose plot (figure 4.2 b and table 3), deviate to some 
extent from the values of the two other fits. When plotted in the effect-per-unit-dose plot the 
data points used in the linear regression do not include the point (D=0, f=1) and are not 
weighted. The values from the curve fit to data for V79 cells, presented in table 8, are based 
on the IR-model. 
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In the case of T-47D cells the discrepancy between values of the LQ-fit and the IR-fit is more 
pronounced. Possibly, the absence of data points below a survival of 0.01 inevitably reduces 
the influence of the  parameter on the fitting. The highest dose of 10 Gy resulted in a 
surviving fraction of 3-4 %, implying a 5 to 10 times higher survival than expected from the  
data of Lorentzen and Furre, which were used for planning of the experiment. The fit with the 
IR-model presumably gives the best values for  and  and is also in better agreement with the 
values obtained from the effect per unit dose plot, but since the comparative studies referred in 
table 7 do not include data for doses below 1 Gy for T-47D cells, the values from the fit with 
the LQ-model are used in table 7. 
 
How much information that is gained from a comparison of the values for the /-ratio is 
doubtful as not only the radiation quality, dose-rate, and experimental set-up but also the cell-
cycle distribution varies. The most trustworthy values for /-ratios are probably those 
obtained using synchronized or confluent cell populations. In exponentially growing cell 
populations, the survival curve is in reality a conjunction of responses of subpopulations with 
different radiosensitivities. 
 
 
 
 
 
 
 
 
 
 Cell cycle 
phase 
Radiation 
quality 
Dose-
rate 
(Gy/min) 
αr  (Gy-1) β (Gy-2) Surviving 
fraction 
at 10Gy 
α⁄β (Gy) 
Ryste 
Hauge, 
2000 
Asynch-
ronous 
220 kVp x-
rays 
0.9 0.24 ± 0.02 0.033 ± 0.006 0.003 7.3 ± 1.3 
Raaphorst 
and 
Boyden, 
1999 
Plateau phase 250 kVp x-
rays 
1.42    7.2 ± 1.9 
Lorentzen, 
2001 
Asynch-
ronous 
80 kVp x-
rays 
1.72 0.16 ± 0.04 0.035 ± 0.005 0.006 4.0 ± 1.2 
Hanisch, 
1998 
Asynch-
ronous 
Linear 
accelerator, 
4.3 MV 
1 0.278 ± 
0.022 
0.0155 ± 
0.0020 
0.01 17.9 ± 2.7 
Furre, 
(Hanisch, 
1998) 
Asynch-
ronous 
Linear 
accelerator, 
4.3 MV 
4 0.269 ± 
0.060 
0.029 ± 
0.0055 
0.004 9.3 ± 2.7 
Present 
study 
(figure 
4.1, table 
1)  
Asynch-
ronous 
Co-60 0.9 0.186 ± 
0.010 
0.0129 ± 
0.0012 
0.04 14.4 ± 1.5 
Table 7: Values of parameters from fits with the LQ-model to survival data for T-47D cells 
from previous studies and the present. The surviving fraction at 10 Gy is calculated from 
equation 2.6 by use of the values of  and  from this table. 
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 Cell cycle 
phase 
Radiati
on 
quality 
Dose-rate 
(Gy/min) 
αs  (Gy-
1) 
αr  (Gy-
1) 
β (Gy-
2) 
Dc 
(Gy) 
Surviving 
fraction 
at 10Gy 
α⁄β 
(Gy) 
Marples 
and Joiner, 
1993 
Asynch-
ronous 
250 
kVp x-
rays 
0.016 & 
0.44 & 1.7 
(dose 
dependent) 
    0.05*  9.2 
Skwarchuk 
et al., 
1993. 
 
Asynch-
ronous 
V79-
WNRE 
cells in 
suspension 
250 
kVp x-
rays 
2.3   0.250 0.0260  0.006 9.6 
Skarsgard 
et al., 
1993. 
 
Asynch-
ronous 
V79-171 
cells in 
suspension 
250 
kVp x-
rays 
2.3   0.225  ± 
0.03 
0.0181 
± 
0.0038 
 0.017 12.4 
± 
3.1 
Tsoulou et 
al., 2001 
Semi-
confluent 
Co-60 1 1.83 ± 
1.07 
0.27 ± 
0.10 
0.02 ± 
0.02 
0.44 ± 
0.28 
0.009 13.5  
Present 
study 
(figure 4.1, 
table 2) 
Asynch-
ronous 
Co-60 0.9 0.54 ± 
0.18 
0.137 ± 
0.002 
0.0183 
± 
0.0002 
0.17 ± 
0.06 
0.04 7.4 
± 
0.1 
Table 8: Values of parameters from fits with the IR-model to survival data for V79 cells from 
previous studies and the present. The surviving fraction at 10 Gy is calculated from equation 
2.6 by use of the values of  and  from this table, except when marked with* in which case 
the value was read from the survival plot. 
 
 
 
 
 Cell cycle 
phase 
Radiation 
quality 
Dose-rate 
(Gy/min) 
αr  (Gy-
1) 
β (Gy-2) Surviving 
fraction 
at 10Gy 
α⁄β 
(Gy) 
Furre, 
1999 
Asynchronous Linear 
accelerator, 
5 MV 
4  0.47 ± 
0.05 
0.042 ± 
0.005 
0.0001 11.2 ± 
1.8 
Pettersen 
and Wang., 
1996 
G1 220 kVp x-
rays 
1.6-1.9   0.00015*    
Present 
study  
(figure 4.1, 
table 1) 
Asynchronous Co-60 0.8 0.12 ± 
0.02 
0.064 ± 
0.004 
0.0005 1.9± 0.3 
Table 9: Values of parameters from fits with the LQ-model to survival data for NHIK 3025 
cells from previous studies and the present. The surviving fraction at 10 Gy is calculated from 
equation 2.6 by use of the values of  and  from this table, except when marked with* in 
which case the value was read from the survival plot. 
 
5.2 THE MIXED CELL POPULATION 
DNA histograms from flow cytometry (see section 3.5) with T-47D cells, revealed the 
intrusion of another cell population a little less than twice the DNA content of parent T-47D 
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cells (figure 4.10 b). Two possibilities were considered: Either a subpopulation of T-47D cells 
could have emerged, having doubled DNA-ploidy or the T-47D culture could accidentally 
have been mixed with cells of one of the other cell lines cultured in the laboratory. 
 
A comparison of the DNA histograms of the mixed cells (T-47Dmix) and NHIK 3025 cells 
(figure 4.10 b and c) discloses very small discrepancies between the DNA-ploidy of NHIK 
3025-cells and the extra stemline appearing in the population measured in figure 4.10 b, and 
suggests a mix-in of NHIK 3025 cells into the T-47D culture. Survival experiments were then 
conducted with NHIK 3025 cells for comparison to the ones carried out for T-47Dmix cells, 
and a curve was constructed based on a calculation of a theoretical mix of T-47D and NHIK 
3025 cells with their respective parametric values. Based on an estimation of the areas of the 
peaks in the DNA histogram for T-47Dmix cells (figure 4.6 b), the calculation was done on a 
mixture of 55 % NHIK 3025 cells and 45 % T-47D cells. 
 
Within the hypersensitive dose range, neither the curve fit based on the IR-model, nor the 
calculated curve for the theoretically mixed population represent close fits to the data, rather 
both curves seem to represent an over-estimation of the survival relative to the averaged data 
points (figure 4.12 b). At the highest doses (shown in figure 4.12 a) the cell kill of the T-
47Dmix cells exceeds what is predicted by the calculated curve of the mixed population. 
However, the discrepancies are not large enough to discredit the hypothesis of the mix-in with 
NHIK 3025 cells. It seems a paradox though, that the response of the mixed cell population is 
closer to that of T-47D cells in the hypersensitive dose range, but to that of NHIK 3025 cells 
for the high dose range, than to the calculated response for the theoretically mixed population. 
One may wonder if the presence of T-47D cells somehow influences on the response of NHIK 
3025 cells in the hypersensitive dose range (i.e. up to 0.5 Gy), while for doses above 2 Gy 
NHIK 3025 cells sensitize T-47D cells. If this is the case, it could be due to micro-
environmental conditioning effects. 
5.2.1 MICRO-ENVIRONMENTAL CONDITIONING EFFECTS 
If the T-47Dmix culture is in fact a mix of T-47D cells and NHIK 3025 cells, the NHIK 3025 
cells must have somehow adapted to a different medium and particularly to trypsinization 
using trypsin with EDTA, which under normal conditions is lethal to these cells. The most 
probable explanation is that T-47D cells have functioned as a kind of feeder cells. Feeder cells 
are normal cells that have been inactivated by gamma irradiation. In culture, these cells can 
serve as a basal layer for other cells and supply important metabolites without further growth 
or division of their own (ATCC, 2003). In this case the T-47D cells are proliferating 
themselves, and it is maybe more correct to assume that both cell lines influence each other 
reciprocally probably by exchange of chemical signaling. 
 
Cells possess complex systems, including receptors, kinases, phosphatases, GTP-binding 
proteins and other molecules, that enable them to send or respond to signals to or from other 
cells. A so-called bystander effect (i.e. the induction of damage in cells that were not directly 
hit by radiation) has been ascribed to the high cell kill at very low doses in cell lines that 
express HRS as a consequence of paracrine or autocrine signaling. A technique called the 
ICM treatment consists in replacing the medium of non-irradiated cells with medium taken 
from cell cultures previously exposed to radiation. Studies applying this technique showed 
that this treatment can reduce clonogenic survival of unexposed cells (Ballarini et al., 2002). 
When medium from irradiated keratinocytes (epithelial cells) was transferred to unirradiated 
keratinocytes or fibroblasts the survival of the unexposed cells was reduced. When the same 
was done with medium from irradiated fibroblasts no effect was observed. Treatment with 
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medium irradiated in absence of cells had no effect on any of the cell lines (Mothersill et al., 
1997). In another investigation by the same authors (Mothersill et al., 1998), it was found that 
the degree of cell-cell contact during irradiation was not significant, whereas the number of 
irradiated cells was the only relevant parameter. 
 
With this in mind it would be reasonable to expect that a mixture of two different cell types 
might behave differently from two coexisting populations without mutual influence, either due 
to mutual exchange or one-way transmission of molecules secreted. 
 
A puzzling aspect is that it was not possible to detect any difference in morphology of the 
mixed population compared to pure T-47D cultures. Normally colonies of NHIK 3025 cells 
grow less densely than colonies of T-47D cells and therefore look quite different. The mixed 
cell population was trypsinized and grown under conditions that are usually harmful to NHIK 
3025 cells and one can not rule our that the morphology NHIK 3025 cell colonies is closer to 
that of T-47D cell colonies grown under the present conditions. The morphology of NHIK 
3025 cell colonies when grown separately under the same conditions can not be tested because 
they will die out. 
5.3 EFFECTS OF REDUCING THE DOSE-RATES OF THE PRIMING 
DOSE 
One of the purposes of this study was to investigate how low the dose-rate of the priming dose 
had to be in order to prevent the induction of the counter-HRS effect. Since HRS was not 
found in NHIK 3025 cells, the HRS observed in the T-47Dmix population must be due to T-
47D cells (also in case it is T-47D cells with changed DNA content that is in the mix) possibly 
mediated to the other cells through micro-environmental conditioning effects, and one can 
argue that the results from the low dose-rate experiments with T-47Dmix cells are at least 
indicative of possible trends. The conclusion to be drawn from the experiments with these 
arguments in mind is that the lowering of the dose-rate of the priming dose to 0.32 Gy/h or 
even 0.045 Gy/h does not prevent a reduction of HRS in response to subsequent irradiation, in 
fact for the lowest dose-rates the HRS seem to have been further reduced (figure 4.19 and 
figure 4.23)  
In the case of T-47D cells given a HDR priming dose, the HRS was observed to be partially 
restored 24 hours after the priming dose; this was not the case for T-47Dmix cells given the 
priming dose with 0.32 Gy/h or 0.045 Gy/h. Instead, the radioresistance for these cells 24 
hours after priming seemed amplified relative to the response 6 hours after the priming. This 
trend is more clearly seen in figures with data plotted without curve fits (figure 4.27) than in 
those having fitted curves included (figures 4.17, 4.21, and 4.25 compared to 4.15, 4.19, and 
4.23, respectively).  
 
The cells that had grown in a medium with tritiated valine had adapted to the continuous 
irradiation. Every week a specimen of cells with incorporated tritium was seeded into medium 
with cold valine and the plating efficiency was compared to the one of a control group. In 
parallel experiments with higher dose-rates (higher activity) the cell population died out after 
a few weeks, but in cells irradiated with 0.01 Gy/h to the cell nucleus, the plating efficiency 
was stabilized at a level of ~50% as compared to the control cells. From the DNA histograms 
in Figure 4.11 a, it appears that the control flask contained the mixed cells (T-47Dmix) while 
from figure 4.11 b the irradiated cells ended up with DNA histograms similar to that of T-47D 
cells (figure 4.10 a), which means that a numerical comparison of the plating efficiencies of 
the control and irradiated cells is irrelevant. It also implies that cells of the cell line mixed into 
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the T-47D population had become extinct while the T-47D cells had adapted to a continuous 
irradiation at 0.01 Gy/h.  
 
When the T-47D cells that had been pre-irradiated with 0.01 Gy by electrons from 
incorporated tritium for several months were challenged by HDR irradiation, the counter-HRS 
effect was found to be fully induced. These cells had received extremely high doses (~30Gy) 
over a very long period (see discussion of the impact of exposure-duration in section 5.5) and 
it remains to be investigated at what point the counter-HRS effect is induced. 
 
5.4. THE LENGTH OF THE INTERVAL BETWEEN PRIMING AND 
CHALLENGE DOSE 
If doses are administered in a way that allows HRS to be repeated, a reversed fractionation 
effect may be obtained, in which a number of very small dose fractions can result in a smaller 
surviving fraction than if the total dose was given as a single dose.  
 
Experiments performed by Short et al. (2001) in order to elucidate the reversed fractionation 
effect, revealed a reduced cell survival in three radioresistant human glioma cell lines, which 
demonstrate HRS, after fractionated acute irradiation with three doses of 0.4 Gy relative to a 
single dose of 1.2 Gy. How much the cell survival was reduced by fractionation was 
dependent on the interval between the dose fractions, and the maximum effect was seen when 
the interval between doses was 3 hours for T98G cells, 4 hours for A7 cells, and about 1 hour 
for U87 cells. The surviving fraction as a function of the interval between the three fractions is 
shown for T98G cell in figure 5.1 as an example. When the interval between fractions was 
increased above those values, there was an increased surviving fraction, which was attributed 
to cell proliferation. 
The minimum cell survival of T98G and U87 correlated to the predicted values assuming a 
full restitution of HRS after each dose but for A7 cells the survival was 50 % higher than the 
predicted value. 
 
In the present study the HRS was found to be strongly reduced in T-47D cells 6 hours after the 
priming exposure and still not completely recovered after 24 hours. This suggests a very 
different timescale for recovery of HRS following a priming dose for these cells as compared 
to those examined by Short et al. Unfortunately, the Rb status of the cell lines used in the 
study of Short et al. is not known, but it is tempting to associate the prolonged timescale in T-
47D cells to the presence of functional pRb, of which it is known that the activation is induced 
over some time (see section 5.6). This would result in a delayed and prolonged effect of a 
priming dose compared to that of cells that depend on the normal radiation-induced G2 delay 
for protective repair (see section 2.1.2). An increase in cell survival was observed when the 
time between dose fractions were increased beyond the values that resulted in the strongest 
HRS (the intervals beyond 3 hours in figure 5.1). Short et al suggested that this increase in cell 
survival was due to cell proliferation. However, if the increased cell survival is not attributed 
to proliferation alone, an alternative explanation to the experimental results of both the present 
study (in which cell proliferation has been corrected for through the plating efficiency of the 
control group) and the one of Short et al. is tempting. This will be presented in the last 
paragraph of section 5.5. 
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Figure 5.1: Survival of exponentially 
growing T98G cells after acute irradiation 
with three doses of 0.4 Gy separated by the 
intervals shown. The solid line and shading 
are the measured SF after a single dose of 
1.2 Gy. The broken line and stippled 
shading are the predicted SF assuming HRS 
occurs after each dose (Short et al., 2001) 
 
 
 
 
In the present study we chose the interval of 6 hours between priming and challenge doses 
with reference to experiments done by Raaphorst and Boyden (1999). They investigated the 
change of response of T-47D cells in plateau phase to a challenge dose of 4 Gy following a 
priming dose of 0.5 Gy, as the interval between the doses was changed, and found that most of 
the response was achieved in 2 hours and persisted for up to 24 hours. Raaphorst and Boyden 
concluded that an interval of 6 hours ensured that most of the response had been established.  
Raaphorst and Boyden found a strong adaptive response at challenge doses of 2 Gy and 4 Gy 
for priming doses of 0.5-2 Gy. When similar experiments were performed with exponentially 
growing T-47D cell cultured in our laboratory (Lorentzen, 2001) no such effect was observed. 
The experiments by Raaphorst and Boyden were done with T-47D cells brought into plateau 
phase by high cell-density, while the cells used in Lorentzens experiments were recultivated 
regularly in order for them to remain in exponential growth. The survival curves of 
Lorentzen’s experiments (the ones for primed and unprimed cells are indistinguishable from 
one another) lie well above Raaphorst and Boyden’s curve of unprimed cells but are 
coincident with their curve for primed cells. Lorentzen suggested that this difference could be 
caused by a permanently induced stress in the cell cultured in our laboratory possibly related 
to the detected presence of the stress-induced protein p53R2 (Graff, unpublished data) 
 
A tempting speculation is that adaptive responses in the high and low dose range may be 
separate phenomena, and that the HRS/IRR is not related to induced repair since it is reduced 
or removed by a priming dose in proliferating cells, that do not express adaptive effects for 
high challenge doses. Instead hypersensitivity at very low doses could be a result of induced 
apoptosis over-running repair processes. The effect of the priming dose then could be to turn 
off the induction of apoptosis. It may be worthwhile to investigate if this turning off-process 
controlled by pRb (see discussion in section 5.6).  
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It follows that the time scales of the two adaptation phenomena (high and low dose range) can 
not be expected to be identical since they relate to different processes.  
 
5.5 A POSSIBLE CORRELATION BETWEEN DOSE-RATE OF 
PRIMING DOSE AND DEGREE OF HRS 
Mitchell and Joiner (2002) investigated combinations of various priming dose sizes and 
priming dose-rates that would affect the response of their glioma cells to an immediate acute 
HDR x-ray exposure. The cell line used was T98G both in asynchronous and confluent 
cultures but since the present study only involves exponentially growing cells, the results with 
the confluent cells will not be discussed here. Priming doses of 2 Gy and 5 Gy were given 
with dose-rates of 0.6, 0.3, 0.1, and 0.05 Gy/h with 60Co γ-rays and were followed by 
immediate acute HDR x-ray exposure.  
 
After a priming dose of 2 or 5 Gy, delivered with varying dose-rates, it appears that the cells 
retain some HRS at all dose-rates, but that the degree of HRS varies depending on the dose-
rate used to deliver the priming dose. This has not been commented on by the authors 
themselves, but a comparison of the αs⁄αr values listed in the paper clearly show, that the 
dose-rate least effective in reducing HRS is 0.1 Gy/h.  
 
The αs⁄αr values for unprimed cells were not reported by Mitchell and Joiner so a comparison 
of the degree of HRS of the pre-irradiated cells relative to cells not pre irradiated can not be 
made. This, in combination with the lack of knowledge of Rb-status in T98G cells and 
differences as to how the experiments were conducted, makes a direct correlation to the 
present results difficult. 
 
There are, however, some observations in the present study that are comparable to those of 
Mitchell and Joiner: For all the examined dose-rates, a very small priming dose of 0.3 Gy was 
enough to reduce the HRS to subsequent challenge irradiation given 6 hours after the priming 
dose. However, even when it was given with HDR (figure 4.3) or 0.9 Gy/h (figure 4.6) the 
HRS was not completely abolished after 6 hours, but when the dose-rate was reduced to 0.32 
Gy (figure 4.19 and figure 4.27 b) and even further to 0.045 Gy/h (figure 4.23 and figure 4.27 
d) the HRS was practically repealed after 6 hours. The experiments with the lowest priming 
dose-rates were performed with the cell culture denoted T-47Dmix, which is T-47D cells with 
another stem line mixed into it. Since the cells mixed into the T-47D cells is most likely  of 
the line NHIK 3025, which does not express HRS, there is reason to believe, that the same 
change in degree of HRS would have been found in a cell culture of only T-47D cells.  
 
The variable effect of various priming dose-rates are interesting from a biological point of 
view because biological processes take time and the duration of irradiation may be important 
as a parameter of its own. An example of molecular effects induced over time is the results of 
Furre et al. (1999 and 2003). Furre et al. irradiated T-47D and NHIK 3025 cells for protracted 
periods with low dose-rates of 0.3 and 0.9 Gy/h and found for both T-47D and NHIK 3025 
cells that the number of cells accumulated in G2-phase increased with time independently of 
the dose-rate. For a certain total dose, the number of cells accumulated in G2-phase was 
therefore higher for the lowest than for the highest dose-rate. The accumulation of cells in G2-
phase as a function of time after an acute HDR dose was also examined for T-47D cells and it 
was found to follow the same time scale as observed for the T-47D cells that were exposed to 
protracted low-dose irradiation.  
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These results of Furre et al. imply that there are molecular mechanisms induced in response to 
radiation that are not dependent on dose size but instead on the irradiation time and how long 
time that has passed after the irradiation. The observations of Mitchell and Joiner and of the 
present study may be viewed as indications that the duration of the exposure is important for 
the response to the priming exposure at the very low dose-rates. A possible explanation to the 
variation in the reduction of HRS as the dose-rate of the priming exposure is changed 
(reflected in the s and s/r values) that is seen in Mitchell an Joiners publication (2002) as 
well as in the present study, is that there may exist two different regulation-pathways when 
inducing mechanisms responsible for reduction of HRS; one pathway dominant for HDR in 
which the induction depends primarily on dose size, and another pathway for LDR, in which 
the induction is time dependent. The suggestion, thus, is that the protection of cells induced by 
a HDR priming dose is triggered by a certain amount of damage. With LDR irradiation used 
for the priming dose this may however be different. Not only the amount of damage may 
activate the process, but also the time over which new damage appear may be of importance.  
 
The lower the dose-rate is, the longer is the exposure time required to deliver a certain dose. If 
the regulation-pathways responsible for the abolition of HRS during LDR need time to get 
induced, then very low dose-rates may provide better time than higher dose-rates for the 
protective mechanisms to reach their full capacity. Thus, there could be a dose-rate for the 
priming dose, which may have little effect in reducing HRS of the following reason: It may 
not be high enough to induce the type of counter-HRS effect that acute irradiation induces. 
However, it may still be low enough to induce the other type of counter-HRS effect, the one 
induced by LDR, but the time at disposal may be too short for the protective mechanisms to 
be fully expressed. An even lower dose-rate may be just as effective in inducing the LDR 
counter-HRS effect, but since irradiation lasts longer, it may allow more time for the full 
effect to develop, and therefore seem more effective than the higher LDR. 
 
Figure 5.2 shows the counter-HRS effect of a HDR priming dose of 0.3 Gy delivered either 6 
hours before the challenge dose () or immediately before the challenge dose ().The 
resulting survival curves suggest that with HDR the complete removal of HRS takes place 
immediately () but is somewhat reduced after 6 hours () (see also figure 4.3). 24 hours 
after the priming dose HRS had partially recovered but still not to its full extend (figure 4.4). 
These findings speak in favor of the theory of two independent pathways for induction of the 
mechanisms for reducing HRS, one for HDR radiation in which the protective mechanisms 
are instantly induced, and another for LDR in which they are induced over time.  
 
It should be investigated, however, if there is a recovery of HRS between 0 and 6 hours after 
the priming dose in T-47D cells as was found in the cell lines examined by Short et al. (2001) 
(see section 5.4 and figure 5.1). This would suggest that the induction pathway of the LDR 
counter-HRS effect is also induced by HDR in addition to the instant responding pathways. If 
this is true, it would imply a correlation between the present results and those of both Short et 
al. (2001) and Mitchell and Joiner (2002): For HDR priming the induction-pathway instantly 
induces mechanisms that remove HRS but the effect only last a few hours (the decrease in 
survival when the interval between doses increases from 0 to 3 hours in figure 5.1). At a 
certain time induction-pathway of the LDR counter-HRS effect, which are induced by both 
HDR and LDR, begin to affect the survival and reduce HRS gradually with time. At 6 hours 
after the HDR priming it was found, in the present experiments, that HRS was reduced but not 
removed and after 24 hours it had partially returned. For LDR-fractionation the duration of the 
exposure should be added to the time between doses, which would explain the fuller effect 
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observed after 6 hours. Possibly, only the LDR priming exposure provides enough time for a 
full induction of these mechanisms, which would explain the very long-lasting counter-HRS 
effect of 24 hours seen only after LDR priming doses, and not after HDR priming doses. 
 
 
Figure 5.2: Surviving fraction of T-47D 
cells as a function of challenge dose are 
shown. (): Cells irradiation with one 
single dose. ():Data from the same 
experiments replotted as HDR challenge 
doses immediately subsequent to a 0.3 
Gy priming dose. (): A 0.3 Gy HDR 
priming dose was given 6 hours before 
the challenge dose. The values for 0 
hours between priming and challenge 
doses () were calculated from the 
values of acute irradiation (): 0.3 Gy 
was deducted from the dose of the 
original experiment and the surviving 
fraction was corrected by division by a 
value of the surviving fraction for 0.3 Gy 
found by inserting the αr, αs, Dc and β 
values from table 2 and d = 0.3 Gy into 
equation 2.7 and 2.6. 
 
 
5.6 THE POSSIBLE INFLUENCE OF pRb 
 
When studying effects of low dose-rates in T-47D and NHIK 3025 cells, Furre et al. (1999 
and 2003) found an inverse dose-rate effect in NHIK 3025 cells but not in T-47D cells. In 
both cell lines accumulation of cells in the radiosensitive G2-phase was observed, but in T-
47D cells this did not result in an enhanced cell kill. The reason for this was attributed to the 
presence of activated pRb in G2 that was found in T-47D cells, which was assumed to be 
radiation-induced since pRb is usually inactive in G2 (see chapter 2.1.2). Activation of pRb 
and binding in the cell nucleus in other cell cycle phases than G1 had previously been 
observed as a stress response following hypoxia (Åmellem et al., 1996, 1998). The activation 
of pRb is not instantaneous, but takes place during the radiation-induced G2-delay and is 
supposed to provide a protection of the individual cells that prevents the enhanced 
radiosensitivity of the G2-phase (Furre et al., 2003). It is not known by what mechanism pRb 
induces radioprotection in G2, but it could perhaps relate to the traditional explanation of the 
need for radiation-induced G2-delay in cells, providing prolonged repair-time before mitosis. 
NHIK 3025 cells are infected with human papilloma virus that induces transcription of 
oncoproteins which bind to the underphosphorylated form of pRb and prevents its normal 
function. In consequence of the present experimental results it is tempting to connect the 
presence of HRS to the presence of functional pRb. 
 
When pRb-activation is considered as a possible determinant for HRS/IRR, this opens for an 
understanding of HRS/IRR, which is quite different from the traditional working hypothesis of 
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an induced repair causing the IRR. Since an immense amount of damage occur at all times as 
the DNA is replicated and as a result of environmental influence, it is more likely that repair 
processes are permanently activated, but that this repair is subdued by apoptosis in case of 
small radiation damages. Only when the radiation dose exceeds the size where a removal of 
all cells receiving radiation damage would endanger the function of the tissue as a whole, is 
the induction of apoptosis turned off, allowing the repair processes to have their effect. pRb is 
a slow responder. It takes time before hypoxia or radiation results in pRb activation, and once 
activated it takes time before the protein is deactivated. Thus, pRb could be involved in the 
LDR counter-HRS effect perhaps through repression of apoptosis. 
 
The cells of the cell line mixed into the T-47D population had become extinct while the T-
47D cells had adapted to a continuous irradiation at 0.01 Gy/h (figure 4.11). If the in-mixed 
cells are of type NHIK 3025, this is understandable since these cells are more radiosensitive 
than T-47D cells on a general basis and particularly so under continuous LDR irradation. 
From the data in figure 4.8 the LDR irradiation has obviously induced an adaptive effect in the 
T-47D cells since no HRS is seen. One can only speculate whether this priming effect of 0.01 
Gy/h also coincides with activation of pRb. This remains to be investigated. 
 
5.7 SOURCES OF ERROR 
When low-dose responses of human cell lines are usually investigated, either a fluorescence-
activated cell sorter (FACS) is used to plate an exact number of cells or the exact number of 
cells is identified after plating by use of microscopic scanning. The method used in the present 
study of estimating the concentration of cells by counting in a Bürker Chamber introduces an 
uncertainty in the number of cells seeded in each flask. The inaccuracy in the concentration 
estimate is corrected for by multiplying the number of cells seeded by the plating efficiency of 
the control flasks, but for very low doses, where the surviving fraction is close to 100 %, only 
small inaccuracies in the volume and homogeneity of the cell suspension administered to each 
flask is enough to obscure observations. In order to reduce these inaccuracies, dilutions of the 
cell suspension was adjusted so, that each flask received 1 ml of cell suspension in distinction 
to 0.2 ml per flask traditionally used in the laboratory, and special attention was paid to keep 
the cells in a homogenous suspension before administering each quantity. 
 
Since the findings in the experiments were both significant and reproducible, it seems that this 
conventional assay is applicable to qualitative studies of low-dose responses but for precise 
quantitative experiments it is necessary to know the exact number of cells plated, and 
application of one of the two alternative assays mentioned above would improve the accuracy 
of the measurements. 
 
The flasks were transported by car between the Radium Hospital and the University (5 km), in 
some cases immediately after irradiation, in other cases when the colonies had grown about a 
week after irradiation. Great care was taken that the cells should not be shaken and in addition 
to transporting the flasks in thermo boxes, the car was pre-heated. 
 
In the irradiation process the time for the shutter to be open to administer a prescribed dose 
was calculated as described in chapter 3.3.2. Since the timer operated exclusively with whole 
seconds, a rounding off was necessary, but this would lead to deviations too small to be 
relevant since the doses are given with only one decimal. 
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The exact distance from the source to the flasks was maintained by use of laser beams from 
laser guns installed in the radiation room for the purpose. Because of a defect mechanism of 
the table used in the first experiments the distance at the irradiation time was 79 cm instead of 
80 cm. This distance was large enough for the source to be considered as a point, so the 
corrections were calculated by use of the inverse square law. 
 
When irradiating with the lowest dose-rate, the open air distance between the blocks and the 
cells was approximately 22 cm, which means that a number of secondary photons (which arise 
from scattering of the primary photons in the roos metal of the shielding blocks) of energies 
lower than those of the two cobalt lines could possibly reach the target. In that case, the dose 
received would originate in an energy spectrum resembling x-ray radiation, which is different 
from the practically monochromatic cobalt radiation. Whether this has any effect on the 
response is doubtful but not eliminable. 
 
5.8 SUGGESTIONS FOR FURTHER INVESTIGATIONS 
The original intention of investigating a possible change in response as the dose-rate of the 
priming dose was varied was impeded by the mixing of another stem-line into the T-47D 
cells. Instead the experiments with the mixed cells revealed a lot of other information that 
would be interesting to pursue in future investigations.  
 
DNA histograms and survival curves indicate that the stemline that was mixed into the T-47D 
cells was NHIK 3025, but small discrepancies in the DNA content and radiation response of 
the mixed cell population relative to what would be theoretically expected of a cell population 
with coexisting T-47D and NHIK 3025 cells, prevent a definite confirmation of the presence 
of NHIK 3025 cells in the mixed population. However, there is no reason why the concept of 
two co-existing populations without mutual influence should apply; the two cell types are 
prone to affect each other chemically and the response as a result of this could well be as 
observed in these experiments. The fact that the mixed-in cell line became extinct after a few 
weeks of irradiation by incorporated tritium, while the T-47D cells adapted to the imposed 
stress, is a strong indication that the cells in the mixed population were of the radiosensitive 
NHIK 3025 cell line. The only observation that remains inexplicable if NHIK 3025 cells are 
in fact the mixed-in cell line is the resemblance in morphology of the mixed cells to pure T-
47D cells. 
 
Experiments are currently being conducted in our laboratory to confirm the presence of NHIK 
3025 cells in the mixed cell population. NHIK 3025 cells with incorporated tritium have been 
observed to have a low and declining survival but this experiment still proceeds. Also a DNA 
histogram of a deliberate mix of 55 % NHIK 3025 cells and 45 % T-47D cell is planned. The 
attempt to get hold of an antibody that can identify the human papilloma virus has not yet 
been successful. 
 
The reason why it is so important to confirm that the mixed-in cell line is NHIK 3025 is that, 
if this is the case, there are interesting implications. T-47D cells that had adapted to the 
continuous LDR irradiation by incorporated tritium were not hypersensitive to low doses, and 
this suggests that the same mechanisms are involved in the adaption to LDR irradiation and in 
HRS/IRR. This connection was confirmed by the facts that NHIK 3025 cells were found not 
to express HRS/IRR and that the putative NHIK 3025 cells did not adapt to the irradiation 
from incorporated tritium. NHIK 3025 cells do not have functional pRb but T-47D cells do. 
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These findings support the theory that pRb is responsible for protective mechanisms induced 
by stress in the form of radiation. 
 
The T-47D cells showed an adaptive response for challenge doses below 1 Gy to priming 
doses of 0.3 Gy given with HDR or LDR (0.9 Gy/h) 6 hours after the priming dose. The HRS 
had not been completely abolished but it was significantly reduced approximately to the same 
level for the two different dose-rates. 24 hours after the priming dose the HRS had partially 
but not completely recovered. Investigations should be made first to establish the time scale 
for both degree of HRS and activation and inactivation of pRb. Then the minimum HDR 
priming dose required in order to obliterate HRS should be found and with that established, a 
regimen of different low dose-rates should be applied to the priming dose. The cells with 
incorporated tritium had been given extremely large doses (~30 Gy) but over an extended 
period with a very small dose-rate to the cell nucleus (0.01 Gy/h). The mechanisms that 
protected the T-47D cells during the continuous irradiation could obviously be the same as 
those responsible for the enhanced resistance relative to cells not pre-irradiated seen after 
subsequent HDR irradiation, so that further experiments as to when this effect occurs after the 
incorporation could probably contribute to a better understanding of these mechanisms. All 
these experiments should be correlated with an examination of the pRb status. 
 
For further understanding of HRS/IRR and in order to test the alternative theory mentioned in 
section 5.6, experiments with very low doses should be conducted that are followed by a 
concrete identification of apoptotic cells. 
 
It would also be interesting to examine the pRb status for the T-47D cells 24 hours after both 
HDR and LDR priming to see if the disappearance or lack of disappearance of HRS is related 
to pRb activation. Does HRS reappear later or is the effect permanent in case of LDR 
priming? 
 
5.9 CLINICAL IMPLICATIONS 
 
Detailed knowledge of the radiation response of the cancer cell stemlines in question can be a 
tool to customizing radiation therapy for better effect. If the cell line of the surrounding tissue 
that is irradiated at very low doses expresses HRS, the risk of inducing cancer is lower than 
current estimates (based on a back-extrapolation of the LQ-curve) suggests. When the dose is 
given in fractions the response could vary depending on the interval between doses in relation 
to the characteristics of the cell line concerned. Fractionated radiation therapy is used to spare 
the late-responding normal tissues but this may have unexpected consequences. If the length 
of the interval allows the HRS to be reestablished, the resulting reversed fractionation effect 
could have unwanted effects in normal tissues exposed to small doses. The same effect may 
also be exploited in irradiation of the tumor cells to improve the therapeutic gain, if only the 
tumor cells and not the surrounding tissue express HRS.  
 
In the clinic doses are traditionally given as 2 Gy HDR doses with 24 hour intervals. The 
surrounding normal tissues will receive smaller doses with the same interval and it is therefore 
important to establish the degree of HRS after 24 hours for low doses. The present results 
indicate a small sparing effect when the second dose is administered. 
.  
If a correlation is found between pRb status and HRS/IRR as well as the adaptive response to 
low doses and its timescale, this could provide an important tool in radiotherapy because 
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cancer cells often have either a mutated Rb gene or a virus infection that prevents the function 
of pRb. It is possible to test the patients for these specific gene products.  
 
If it is proved that the stem line that had been mixed into the T-47D cells was NHIK 3025, the 
extinction of the NHIK 3025 while the T-47D were adapted to the continuous irradiation of 
0.01 Gy/h to the cell nucleus might have implications for brachytherapy to tumor cells with 
dysfunctional pRb. The experiment with cells with incorporated tritium of this study suggests 
that the tumor cells could be eradicated by a treatment with very low dose-rate, that would be 
lenient towards the pRb protected normal tissues.  
 
In and around a tumor, different cell stemlines co-exist. The experimental results of this study 
suggest that the response of a cell population is changed by the presence of cells from other 
stemlines. Whether this is also true in vivo remains to be investigated. 
 
The indications of the present study that the very lowest dose-rate induce a counter-HRS 
effect to subsequent irradiation that disappears when the dose-rate is slightly increased and re-
appears for priming with higher dose-rates has implications for brachytherapy. In 
brachytherapy the tissues surrounding the actual target will be irradiated at dose-rates 
diminishing with the distance from the source which implies that at a certain distance the 
normal tissue will be harmed to a greater extend than normally expected. 
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6 CONCLUSION 
 
The results of the present study give rise to a lot of speculations, but not many conclusions can 
be drawn without supplementary investigations. 
 
 
The main findings are:  
 
 
• T-47D cells clearly express both HRS/IRR and the adaptive response in the low-dose 
range (below 1 Gy).  
 
• NHIK 3025 cells do not express HRS/IRR. 
 
• T-47D cells that had been pre-irradiated by tritium-decay electrons did not express 
HRS/IRR. 
 
• T-47D cells with functional pRb adapted to the continuous irradiation with electrons 
from incorporated tritium, while the putative NHIK 3025 cells without functional pRb 
were eradicated by the same treatment. 
 
• When priming doses were delivered with the lowest dose-rates used (i.e. 0.32 Gy/h 
and 0.045 Gy/h) the priming effect as measured 6 hours following the termination of 
the priming exposure seemed to be larger than when the priming dose was delivered 
with higher dose-rates (i.e. HDR or 0.9 Gy/h). 
 
• 24 hours after the priming doses delivered with 0.32 Gy/h and 0.045 Gy/h, HRS was 
still absent (perhaps even further reduced), while 24 hours after a HDR priming dose 
HRS was partially restored. 
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APPENDIX A: List of Chemicals 
 
Below is a list of chemicals used in this study in alphabetic order. The list states the 
manufacturer of each chemical. 
 
 
 
 
CHEMICAL MANUFACTURER 
  
Methylene blue Merck (Germany) 
EDTA (Ethylenediaminetetraacetic acid) Fluka (Switzerland 
Ethanol 96% Arcus produkter AS (Oslo) 
Foetal bovine serum Gibco (Germany) 
Glucose Merck (Germany) 
Insulin Novo Nordisk AS (Denmark) 
KCl Merck (Germany) 
L-Glutamine 
 
Sigma (USA) 
MEM powder w/Hanks Gibco (Scotland) 
Milli-Q water Millipore (USA) 
NaCl Riedel de Haën (Germany) 
NaHCO3 Norsk Medisinaldepot (Oslo) 
Penicillin-Streptomycin (5000 IU/ml – 5000 
µg/ml) 
Gibco (Scotland) 
Phenol red Merck (Germany) 
RPMI 1640 powder, w/L-glutamine, w/o 
NaHCO3 
Gibco (Scotland) 
Trypsin powder Boehringer Mannheim (Germany) 
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APPENDIX B: Recipes 
 
 
RPMI 1640 medium 
1 liter stem solution: 
 
RPMI 1640 powder 10.43 g 
NaHCO3 2.00 g 
Milli-Q H2O  1.00 ltr 
 
1 liter RPMI medium with serum: 
 
RPMI 1640 stem solution 880 ml 
Foetal calf serum (10%) 100 ml 
Penicillin/streptomycin 10 ml 
Insulin (200 units/l) 2 ml 
L-Glutamine 10 ml 
 
 
MEM medium 
 
1 liter stem solution:  
 
MEM powder 10.63 g 
Milli-Q H2O 1 ltr 
NaHCO3 2.4 g 
 
 
1 liter MEM medium with serum: 
 
MEM with Hanks 810 ml 
Foetal calf serum (10%) 150 ml 
Penicillin/streptomycin 20 ml 
L-glutamine 10 ml 
 
 
TRYPSIN 
 
1 Liter trypsin stem solution: 
 
NaCl 8.00 g 
KCl 0.40 g 
Glucose 1.00 g 
NaHCO3 0.35 g 
Phenol Red 0.02 g 
  
1 liter trypsin with EDTA: 
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Trypsin stem solution 1.0 ltr 
EDTA 200 mg 
Trypsin powder 500 mg 
 
 
L-GLUTAMINE, 35 ml 
 
L-glutamine 1.0227 g 
RPMI or MEM stem solution 35 ml 
 
 
COLD VALINE, 82.9 mM solution 
 
L-Valine powder 1.00 g 
RPMI stem solution 103 ml 
 
PBS, 1 liter 
NaCl 8.000 g 
KCl 0.201 g 
KH2PO4 0.204 g 
NaHPO4•12H2O 2.858 g 
Milli-Q H2O 1 ltr 
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APPENDIX C: List of experiments 
 
 
 
 
 
Experiment 
number 
Cell line Primin
g dose 
(Gy) 
Priming 
dose-rate 
(Gy/h) 
Challenge doses 
/ acute doses 
(Gy) 
Time between 
priming and 
challenge 
dose (h) 
V1-V3 V 79 none  0.5, 1, 2, 5, 7.5, 10, 
14 
 
V4-V6 V 79 none  0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
 
T1-T3 T-47D none  0.5, 1, 2, 5, 7.5, 10  
T4-T6 T-47D none  0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
 
T7, T8, T10 T-47D 
(T7+T8), 
T-47Dmix (T10) 
0.3 HDR  0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
6 and 24 
T9 T-47D 0.3 0.9 0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
6 (24 was 
infected) 
T11, T14, T15 T-47Dmix 0.3 0.32 0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
6 and 24 
T13, T16, T18 T-47Dmix 0.3 0.045 0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
6 and 24 
T12, T17, 
T19(infected) 
T-47D 24.7 
(T12), 
36.2 
(T17)  
0.01 0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
(6) 
T20-T22 T-47Dmix None  0.1, 0.2, 0.5, 0.75, 1, 
2, 5, 7.5, 10 
 
N1-N3 NHIK 3025 None  0.1, 0.2, 0.5, 0.75, 1, 
2, 5 
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APPENDIX D: Experimental raw data 
 
In this appendix all raw data from the experiments are listed. The characteristics of each 
experiment are summarized in appendix C. In appendix D the raw data of experiments with 
similar procedures are listed together and data of each group are summarized in a plot 
showing surviving fraction as a function of dose for each individual experiment  
 
 
I: T-47D, acute irradiation, no priming dose  
 
Experiment: T1
Multiplicity M= 1.854 0.366
Dose (Gy) Control 0.51 1.03 2.06 5.12 7.69 10.24
flask 1 64 63 79 113 241 329 311
flask 2 75 76 84 184 178 293 302
flask 3 81 49 82 126 183 273 282
flask 4 70 94 74 117 182 320 250
flask 5 76 73 57 128 169 374 256
Number of cells seeded per flask 200 200 200 400 1000 4000 10000
Mean number of colonies per flask: N 73.2 71.0 75.2 133.6 190.6 317.8 280.2
∆N 2.89 7.44 4.85 12.90 12.84 17.19 12.09
Number of cells seeded multiplied with 
PE: N0 73.2 73.2 146.4 366 1464 3660
∆N0 2.888 2.888 5.776 14.440 57.758 144.395
Surviving fraction: SF 0.970 1.027 0.913 0.521 0.217 0.077
∆SF 0.109 0.078 0.095 0.041 0.015 0.004
Surviving fraction corrected for 
multiplicity: f 0.879 0.928 0.754 0.331 0.124 0.042
∆f 0.308 0.289 0.168 0.032 0.009 0.003
January 9, 2002.
Plating efficiency PE=
 
 
Experiment: T2
Multiplicity M= 1.826 0.43
Dose (Gy) Control 0.51 1.03 2.06 5.12 7.69 10.24
flask 1 102 100 68 158 272 371 265
flask 2 79 63 77 152 256 380 223
flask 3 87 74 73 169 174 374 274
flask 4 77 89 108 163 187 373 286
flask 5 85 74 99 154 196 400 307
Number of cells seeded per flask 200 200 200 400 1000 4000 10000
Mean number of colonies per flask: N 86.0 80.0 85.0 159.2 217.0 379.6 271.0
∆N 4.40 6.49 7.82 3.09 19.67 5.32 13.91
Number of cells seeded multiplied with 
PE: N0 86 86 172 430 1720 4300
∆N0 4.405 4.405 8.809 22.023 88.091 220.227
Surviving fraction: SF 0.930 0.988 0.926 0.505 0.221 0.063
∆SF 0.089 0.104 0.051 0.053 0.012 0.005
Surviving fraction corrected for 
multiplicity: f 0.796 0.947 0.787 0.324 0.128 0.035
∆f 0.175 0.397 0.097 0.041 0.007 0.003
January 16, 2002.
Plating efficiency PE=
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Experiment: T3
Multiplicity M= 1.826 0.691
Dose (Gy) Control 0.51 1.03 2.06 5.12 7.69 10.24
flask 1 105 145 129 298 409 416 361
flask 2 145 111 110 257 331 375 338
flask 3 125 108 137 248 306 423 352
flask 4 157 130 112 215 330 458 346
flask 5 159 120 166 216 310 496 416
Number of cells seeded per flask 200 200 200 400 1000 4000 10000
Mean number of colonies per flask: N 138.2 122.8 130.8 246.8 337.2 433.6 362.6
∆N 10.27 6.75 10.17 15.31 18.65 20.43 13.87
Number of cells seeded multiplied with 
PE: N0 138.2 138.2 276.4 691 2764 6910
∆N0 10.268 10.268 20.537 51.342 205.368 513.420
Surviving fraction: SF 0.889 0.946 0.893 0.488 0.157 0.052
∆SF 0.082 0.102 0.086 0.045 0.014 0.004
Surviving fraction corrected for 
multiplicity: f 0.723 0.830 0.730 0.311 0.090 0.029
∆f 0.130 0.224 0.140 0.035 0.008 0.002
January 23, 2002.
Plating efficiency PE=
 
 
 
Experiment: T4
Multiplicity M= 1.826 0.747
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 154 148 155 150 123 123 199 173
flask 2 157 134 122 130 142 148 196 172
flask 3 159 136 145 139 134 142 224 168
flask 4 130 102 134 145 101 129 201 115
flask 5 147 126 144 122 141 139 189 183
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 149.4 129.2 140.0 137.2 128.2 136.2 201.8 162.2
∆N 5.26 7.66 5.59 5.05 7.60 4.51 5.91 12.06
Number of cells seeded multiplied with 
PE: N0 149.4 149.4 149.4 149.4 149.4 298.8 597.6
∆N0 5.259 5.259 5.259 5.259 5.259 10.519 21.037
Surviving fraction: SF 0.865 0.937 0.918 0.858 0.912 0.675 0.271
∆SF 0.060 0.050 0.047 0.059 0.044 0.031 0.022
Surviving fraction corrected for 
multiplicity: f 0.687 0.810 0.774 0.678 0.762 0.470 0.160
∆f 0.086 0.102 0.086 0.084 0.078 0.030 0.014
March 7, 2002
Plating efficiency PE=
 
 
T-47D acute irradiation (large doses)
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Experiment: T5
Multiplicity M= 1.927 0.461
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 85 83 74 84 92 95 158 163
flask 2 81 89 87 106 71 88 157 164
flask 3 110 75 79 69 83 77 148 148
flask 4 93 92 68 93 88 82 145 191
flask 5 92 97 90 84 90 84 156 171
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 92.2 87.2 79.6 87.2 84.8 85.2 152.8 167.4
∆N 4.97 3.80 4.06 6.08 3.76 3.02 2.63 6.99
Number of cells seeded multiplied with 
PE: N0 92.2 92.2 92.2 92.2 92.2 184.4 368.8
∆N0 4.974 4.974 4.974 4.974 4.974 9.948 19.896
Surviving fraction: SF 0.946 0.863 0.946 0.920 0.924 0.829 0.454
∆SF 0.066 0.064 0.083 0.064 0.060 0.047 0.031
Surviving fraction corrected for 
multiplicity: f 0.794 0.653 0.794 0.743 0.751 0.608 0.271
∆f 0.145 0.090 0.184 0.117 0.112 0.059 0.022
March 13, 2002
Plating efficiency PE=
 
 
Experiment: T6
Multiplicity M= 1.807 0.722
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 140 154 139 124 113 127 235 296
flask 2 149 133 137 139 130 136 208 320
flask 3 140 141 120 136 124 130 265 279
flask 4 152 129 140 111 130 128 257 272
flask 5 141 149 124 118 126 143 242 280
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 144.4 141.2 132.0 125.6 124.6 132.8 241.4 289.4
∆N 2.54 4.69 4.16 5.30 3.12 2.99 9.89 8.60
Number of cells seeded multiplied with 
PE: N0 144.4 144.4 144.4 144.4 144.4 288.8 577.6
∆N0 2.542 2.542 2.542 2.542 2.542 5.083 10.167
Surviving fraction: SF 0.978 0.914 0.870 0.863 0.920 0.836 0.501
∆SF 0.037 0.033 0.040 0.026 0.026 0.037 0.017
Surviving fraction corrected for 
multiplicity: f 0.915 0.772 0.701 0.690 0.782 0.653 0.324
∆f 0.112 0.059 0.059 0.038 0.048 0.050 0.014
March 20, 2002
Plating efficiency PE=
 
 
T-47D acute irradiation (small doses)
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IIa: T-47D, 0.3 Gy HDR priming dose 6 hours before acute 
irradiation. 
 
Experiment: T7/6
Multiplicity M= 1.090 0.39667
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 121 110 100 113 75 96 90 53
flask 2 125 126 116 86 100 117 114 45
flask 3 150 123 126 105 117 86 125 65
flask 4 107 120 118 118 99 120 121 47
flask 5 92 110 123 107 89 84 103 65
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 119.0 117.8 116.6 105.8 96.0 100.6 110.6 55.0
∆N 9.68 3.32 4.51 5.45 6.91 7.60 6.36 4.29
Number of cells seeded multiplied with 
PE: N0 119 119 119 119 119 158.667 317.333
∆N0 9.680 9.680 9.680 9.680 9.680 12.907 25.813
Surviving fraction: SF 0.990 0.980 0.889 0.807 0.845 0.697 0.173
∆SF 0.085 0.088 0.086 0.088 0.094 0.069 0.020
Surviving fraction corrected for 
multiplicity: f 0.989 0.978 0.880 0.792 0.833 0.677 0.161
∆f 0.093 0.097 0.092 0.093 0.100 0.072 0.018
June 6, 2002
Plating efficiency PE=
 
 
Experiment: T8/6
Multiplicity M= 1.109 0.51333
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 161 149 140 130 140 106 132 60
flask 2 140 134 136 143 122 112 135 59
flask 3 156 140 151 132 132 109 103 68
flask 4 147 127 153 128 121 123 166 70
flask 5 166 142 124 134 134 114 129 42
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 154.0 138.4 140.8 133.4 129.8 112.8 133.0 59.8
∆N 4.70 3.72 5.29 2.60 3.64 2.89 10.02 4.94
Number of cells seeded multiplied with 
PE: N0 154 154 154 154 154 205.333 410.667
∆N0 4.701 4.701 4.701 4.701 4.701 6.268 12.536
Surviving fraction: SF 0.899 0.914 0.866 0.843 0.732 0.648 0.146
∆SF 0.037 0.044 0.031 0.035 0.029 0.053 0.013
Surviving fraction corrected for 
multiplicity: f 0.888 0.905 0.853 0.827 0.710 0.622 0.133
∆f 0.040 0.049 0.034 0.038 0.031 0.054 0.012
June 12, 2002
Plating efficiency PE=
 
 
T-47D, 0.3Gy HDR primer, 6 hours interval
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IIb: T-47D, 0.3 Gy HDR priming dose 24 hours before 
acute irradiation. 
 
Experiment: T7/24
Multiplicity M= 1.417 0.72
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 140 93 173 126 131 125 185 159
flask 2 159 143 139 99 120 106 213 177
flask 3 139 112 121 124 102 80 154 222
flask 4 138 117 144 131 114 120 212 179
flask 5 144 109 137 169 147 113 203 193
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 144.0 114.8 142.8 129.8 122.8 108.8 193.4 186.0
∆N 3.89 8.11 8.48 11.26 7.65 7.88 11.06 10.50
Number of cells seeded multiplied with 
PE: N0 144 144 144 144 144 288 576
∆N0 5.259 5.259 5.259 5.259 5.259 5.259 5.259
Surviving fraction: SF 0.797 0.992 0.901 0.853 0.756 0.672 0.323
∆SF 0.063 0.069 0.085 0.062 0.061 0.040 0.018
Surviving fraction corrected for 
multiplicity: f 0.712 0.986 0.847 0.782 0.662 0.569 0.246
∆f 0.077 0.116 0.119 0.080 0.071 0.043 0.015
June 6, 2002
Plating efficiency PE=
 
 
Experiment: T8/24
Multiplicity M= 1.417 0.618
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 114 121 128 103 121 94 164 233
flask 2 112 105 121 104 107 110 187 159
flask 3 101 111 117 117 107 107 180 153
flask 4 121 115 106 96 115 103 198 154
flask 5 170 129 91 116 104 102 198 173
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 123.6 116.2 112.6 107.2 110.8 103.2 185.4 174.4
∆N 12.04 4.13 6.47 4.04 3.14 2.71 6.35 15.08
Number of cells seeded multiplied with 
PE: N0 123.6 123.6 123.6 123.6 123.6 247.2 494.4
∆N0 12.036 12.036 12.036 12.036 12.036 24.072 48.143
Surviving fraction: SF 0.940 0.911 0.867 0.896 0.835 0.750 0.353
∆SF 0.097 0.103 0.091 0.091 0.084 0.077 0.046
Surviving fraction corrected for 
multiplicity: f 0.904 0.861 0.801 0.841 0.759 0.656 0.270
∆f 0.147 0.147 0.121 0.127 0.107 0.089 0.039
June 12, 2002
Plating efficiency PE=
 
 
T-47D, 0.3 Gy HDR primer, 24 hours interval
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III: T-47D, 0.3 Gy priming dose, dose-rate 0.9 Gy/h, 6 
hours before acute irradiation. 
 
 
 
Experiment: T9/6
Multiplicity M= 1.132 0.31467
Dose (Gy) Control 0.1 0.2 0.5 0.76 1 2.1 5.1
flask 1 105 84 71 98 79 69 74 52
flask 2 75 83 80 88 80 78 85 55
flask 3 90 77 88 102 79 74 88 50
flask 4 85 88 88 81 81 76 83 69
flask 5 117 99 90 86 74 75 82 51
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 94.4 86.2 83.4 91.0 78.6 74.4 82.4 55.4
∆N 7.44 3.65 3.54 3.90 1.21 1.50 2.34 3.50
Number of cells seeded multiplied with 
PE: N0 94.4 94.4 94.4 94.4 94.4 125.867 251.733
∆N0 7.440 7.440 7.440 7.440 7.440 9.921 19.841
Surviving fraction: SF 0.913 0.883 0.964 0.833 0.788 0.655 0.220
∆SF 0.082 0.079 0.086 0.067 0.064 0.055 0.022
Surviving fraction corrected for 
multiplicity: f 0.901 0.868 0.959 0.813 0.764 0.624 0.199
∆f 0.091 0.088 0.098 0.073 0.069 0.057 0.021
June 19, 2002
Plating efficiency PE=
 
 
 
 
 
 
 
 
 
 
T-47D, 0.3 Gy primer with dose rate 0.9 Gy/h, 6 hours interval
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IV: T-47Dmix, 0.3 Gy HDR priming dose, 6 and 24 hours 
before acute irradiation. 
 
Experiment: T10/6
Multiplicity M= 1.161 0.65
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 195 188 172
flask 2 194 215 194 183
flask 3 196 210 168 168 182 177
flask 4 202 191 188 173 188 186
flask 5 192 184 178 189 161
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 195.0 209.0 192.3 185.0 173.0 181.7 185.3 170.0
∆N 0.58 3.79 0.88 1.53 2.89 6.84 1.76 4.73
Number of cells seeded multiplied with 
PE: N0 195 195 195 195 195 260 520
∆N0 0.577 0.577 0.577 0.577 0.577 0.770 1.540
Surviving fraction: SF 1.072 0.986 0.949 0.887 0.932 0.713 0.327
∆SF 0.020 0.005 0.008 0.015 0.035 0.007 0.009
Surviving fraction corrected for 
multiplicity: f 1.087 0.984 0.940 0.869 0.920 0.678 0.294
∆f 0.024 0.006 0.010 0.017 0.041 0.008 0.009
November 20, 2002
Plating efficiency PE=
 
 
Experiment: T10/24
Multiplicity M= 1.533 0.816
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 190 143 162 185 150 171 264 270
flask 2 147 156 160 165 133 167 274 318
flask 3 152 184 172 135 149 157 249 270
flask 4 166 158 143 160 166 148 232 262
flask 5 161 156 164 158 148 160 233 308
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 163.2 159.4 160.2 160.6 149.2 160.6 250.4 285.6
∆N 7.48 6.71 4.76 7.99 5.23 4.01 8.32 11.39
Number of cells seeded multiplied with 
PE: N0 163.2 163.2 163.2 163.2 163.2 326.4 652.8
∆N0 7.479 7.479 7.479 7.479 7.479 14.959 29.917
Surviving fraction: SF 0.977 0.982 0.984 0.914 0.984 0.767 0.438
∆SF 0.061 0.054 0.067 0.053 0.051 0.043 0.027
Surviving fraction corrected for 
multiplicity: f 0.953 0.962 0.967 0.844 0.967 0.645 0.321
∆f 0.117 0.106 0.133 0.083 0.102 0.051 0.022
November 20, 2002
Plating efficiency PE=
 
 
 
T-47Dmix, 0.3 Gy HDR primer , 6 and 24 hour intervals
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Va: T-47Dmix, 0.3 Gy priming dose, dose-rate 0.32 Gy/h, 6 
hours before acute irradiation. 
 
Experiment: T11/6
Multiplicity M= 1.282 0.64867
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 163 199 192 175 146 179 193 170
flask 2 205 191 153 194 183 166 191 182
flask 3 200 203 199 189 155 153 180 168
flask 4 220 188 200 174 166 160 187 167
flask 5 185 144 193 178 208 147 189 165
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 194.6 185.0 187.4 182.0 171.6 161.0 188.0 170.4
∆N 9.68 10.60 8.74 4.01 10.99 5.52 2.24 3.01
Number of cells seeded multiplied with 
PE: N0 194.6 194.6 194.6 194.6 194.6 259.467 518.933
∆N0 9.678 9.678 9.678 9.678 9.678 12.904 25.807
Surviving fraction: SF 0.951 0.963 0.935 0.882 0.827 0.725 0.328
∆SF 0.072 0.066 0.051 0.072 0.050 0.037 0.017
Surviving fraction corrected for 
multiplicity: f 0.933 0.949 0.913 0.845 0.779 0.661 0.272
∆f 0.095 0.088 0.066 0.089 0.059 0.041 0.015
November 26, 2002
Plating efficiency PE=
 
 
Experiment: T14/6
Multiplicity M= 1.294 0.262
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 57 36 55 42 46 50 63 51
flask 2 40 46 41 44 43 41 59 51
flask 3 62 47 41 58 41 53 47 46
flask 4 59 54 59 52 56 41 57 47
flask 5 44 40 44 55 54 49 48 43
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 52.4 44.6 48.0 50.2 48.0 46.8 54.8 47.6
∆N 4.37 3.09 3.77 3.10 2.98 2.46 3.14 1.54
Number of cells seeded multiplied with 
PE: N0 52.4 52.4 52.4 52.4 52.4 78.6 157.2
∆N0 4.366 4.366 4.366 4.366 4.366 6.549 13.097
Surviving fraction: SF 0.851 0.916 0.958 0.916 0.893 0.697 0.303
∆SF 0.092 0.105 0.099 0.095 0.088 0.070 0.027
Surviving fraction corrected for 
multiplicity: f 0.805 0.886 0.942 0.886 0.857 0.629 0.248
∆f 0.112 0.136 0.134 0.123 0.111 0.076 0.024
December 12, 2002
Plating efficiency PE=
 
 
Experiment: T15/6
Multiplicity M= 1.157 0.421
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 71 81 80 89 71 58 125 94
flask 2 82 92 92 79 73 59 116 101
flask 3 87 89 80 94 80 66 102 103
flask 4 90 78 89 72 69 79 71 97
flask 5 91 78 77 66 73 84 94 109
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 84.2 83.6 83.6 80.0 73.2 69.2 101.6 100.8
∆N 3.65 2.91 2.91 5.19 1.85 5.27 9.35 2.58
Number of cells seeded multiplied with 
PE: N0 84.2 84.2 84.2 84.2 84.2 126.3 252.6
∆N0 3.652 3.652 3.652 3.652 3.652 5.479 10.957
Surviving fraction: SF 0.993 0.993 0.950 0.869 0.822 0.804 0.399
∆SF 0.055 0.055 0.074 0.044 0.072 0.082 0.020
Surviving fraction corrected for 
multiplicity: f 0.992 0.992 0.941 0.849 0.796 0.777 0.363
∆f 0.065 0.065 0.086 0.049 0.079 0.090 0.019
January 9, 2003
Plating efficiency PE=
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Vb: T-47Dmix, 0.3 Gy priming dose, dose-rate 0.32 Gy/h, 
24 hours before acute irradiation. 
 
Experiment: T11/24
Multiplicity M= 1.609 0.713
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 147 171 142 142 130 139 245 289
flask 2 154 127 165 133 131 142 215 291
flask 3 117 143 137 129 141 158 231 322
flask 4 142 126 165 138 157 128 225 279
flask 5 153 139 147 133 144 107 239 278
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 142.6 141.2 151.2 135.0 140.6 134.8 231.0 291.8
∆N 6.76 8.15 5.85 2.26 4.93 8.45 5.25 7.98
Number of cells seeded multiplied with 
PE: N0 142.6 142.6 142.6 142.6 142.6 285.2 570.4
∆N0 6.757 6.757 6.757 6.757 6.757 13.514 27.029
Surviving fraction: SF 0.990 1.060 0.947 0.986 0.945 0.810 0.512
∆SF 0.074 0.065 0.048 0.058 0.074 0.043 0.028
Surviving fraction corrected for 
multiplicity: f 0.976 1.258 0.884 0.966 0.882 0.677 0.370
∆f 0.176 0.841 0.089 0.134 0.139 0.054 0.024
November 26, 2002
Plating efficiency PE=
 
T-47Dmix, 0.3 Gy  primer with dose rate 0.32 Gy/h, 6 hour interval
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Experiment: T14/24
Multiplicity M= 1.498 0.313
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 62 63 61 63 56 50 67 114
flask 2 53 44 66 66 58 54 64 102
flask 3 70 56 55 70 55 46 78 77
flask 4 73 62 67 51 57 58 78 63
flask 5 55 66 50 66 61 47 87
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 62.6 58.2 59.8 63.2 57.4 51.0 71.8 88.6
∆N 3.96 3.90 3.25 3.25 1.03 2.24 3.66 8.99
Number of cells seeded multiplied with 
PE: N0 62.6 62.6 62.6 62.6 62.6 93.9 187.8
∆N0 3.957 3.957 3.957 3.957 3.957 5.936 11.872
Surviving fraction: SF 0.930 0.955 1.010 0.917 0.815 0.764 0.472
∆SF 0.086 0.080 0.082 0.060 0.063 0.062 0.056
Surviving fraction corrected for 
multiplicity: f 0.875 0.918 1.019 0.855 0.713 0.651 0.357
∆f 0.137 0.136 0.170 0.093 0.080 0.073 0.049
December 12, 2002
Plating efficiency PE=
 
 
Experiment: T15/24
Multiplicity M= 1.549 0.513
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 83 106 118 114 103 94 133 165
flask 2 96 118 98 105 117 91 131 163
flask 3 119 109 117 85 94 113 125 190
flask 4 102 103 105 118 94 103 138 178
flask 5 113 109 101 104 120 106 154 190
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 102.6 109.0 107.8 105.2 105.6 101.4 136.2 177.2
∆N 6.35 2.51 4.12 5.70 5.54 4.01 4.91 5.83
Number of cells seeded multiplied with 
PE: N0 102.6 102.6 102.6 102.6 102.6 153.9 307.8
∆N0 6.345 6.345 6.345 6.345 6.345 9.518 19.035
Surviving fraction: SF 1.062 1.051 1.025 1.029 0.988 0.885 0.576
∆SF 0.070 0.076 0.084 0.083 0.073 0.063 0.040
Surviving fraction corrected for 
multiplicity: f 1.176 1.134 1.061 1.071 0.975 0.796 0.440
∆f 0.272 0.251 0.219 0.224 0.151 0.094 0.038
January 9, 2003
Plating efficiency PE=
 
 
T-47Dmix, 0.3 Gy  primer with dose rate 0.32 Gy/h, 24 hour interval
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VIa: T-47Dmix, 0.3 Gy priming dose, dose-rate 0.045 Gy/h, 
6 hours before acute irradiation. 
 
Experiment: T13/6
Multiplicity M= 1.145 0.595
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 172 169 163 177 151 158 169 153
flask 2 185 153 183 162 153 156 177 113
flask 3 188 168 149 148 153 176 143
flask 4 152 173 168 157 136 165 132
flask 5 143 166 139 158 138 176 141
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 178.5 161.0 170.6 159.0 153.4 148.2 172.6 136.4
∆N 6.50 7.94 3.50 6.76 1.86 4.65 2.38 6.73
Number of cells seeded multiplied with 
PE: N0 178.5 178.5 178.5 178.5 178.5 238 476
∆N0 6.500 6.500 6.500 6.500 6.500 8.667 17.333
Surviving fraction: SF 0.902 0.956 0.891 0.859 0.830 0.725 0.287
∆SF 0.055 0.040 0.050 0.033 0.040 0.028 0.018
Surviving fraction corrected for 
multiplicity: f 0.888 0.949 0.875 0.840 0.808 0.695 0.259
∆f 0.062 0.046 0.056 0.037 0.044 0.030 0.016
December 5, 2002
Plating efficiency PE=
 
 
Experiment: T16/6
Multiplicity M= 1.156 0.516
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 117 117 124 83 74 91 116 82
flask 2 90 114 98 95 102 87 120 83
flask 3 102 110 113 109 108 89 116 97
flask 4 97 100 85 91 85 96 100 73
flask 5 110 94 88 105 86 80 105 49
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 103.2 107.0 101.6 96.6 91.0 88.6 111.4 76.8
∆N 4.75 4.34 7.43 4.71 6.16 2.62 3.79 7.94
Number of cells seeded multiplied with 
PE: N0 103.2 103.2 103.2 103.2 103.2 154.8 309.6
∆N0 4.748 4.748 4.748 4.748 4.748 7.121 14.243
Surviving fraction: SF 1.037 0.984 0.936 0.882 0.859 0.720 0.248
∆SF 0.064 0.085 0.063 0.072 0.047 0.041 0.028
Surviving fraction corrected for 
multiplicity: f 1.044 0.982 0.925 0.863 0.837 0.686 0.221
∆f 0.077 0.100 0.072 0.081 0.052 0.044 0.026
January 15, 2003
Plating efficiency PE=
 
 
Experiment: T18/6
Multiplicity M= 1.121 0.475
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 93 96 92 78 81 71 125 56
flask 2 107 70 95 97 82 81 113 54
flask 3 83 92 91 94 74 97 114 58
flask 4 85 118 90 97 89 88 123 44
flask 5 107 82 95 88 83 90 95 60
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 95.0 91.6 92.6 90.8 81.8 85.4 114.0 54.4
∆N 5.18 7.98 1.03 3.60 2.40 4.41 5.31 2.79
Number of cells seeded multiplied with 
PE: N0 95 95 95 95 95 142.5 285
∆N0 5.177 5.177 5.177 5.177 5.177 7.765 15.531
Surviving fraction: SF 0.964 0.975 0.956 0.861 0.899 0.800 0.191
∆SF 0.099 0.054 0.064 0.053 0.067 0.057 0.014
Surviving fraction corrected for 
multiplicity: f 0.960 0.971 0.950 0.845 0.887 0.779 0.174
∆f 0.111 0.061 0.072 0.058 0.074 0.061 0.013
January 22, 2003
Plating efficiency PE=
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VIb: T-47Dmix, 0.3 Gy priming dose, dose-rate 0.045 Gy/h, 
24 hours before acute irradiation. 
 
Experiment: T13/24
Multiplicity M= 1.599 0.647
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 109 121 116 118 135 113 201 267
flask 2 138 115 117 133 123 122 202 234
flask 3 145 118 138 130 120 115 225 254
flask 4 139 105 108 123 117 117 211 246
flask 5 116 139 139 127 103 111 202 233
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 129.4 119.6 123.6 126.2 119.6 115.6 208.2 246.8
∆N 7.09 5.55 6.28 2.63 5.15 1.89 4.58 6.38
Number of cells seeded multiplied with 
PE: N0 129.4 129.4 129.4 129.4 129.4 258.8 517.6
∆N0 7.089 7.089 7.089 7.089 7.089 14.179 28.358
Surviving fraction: SF 0.924 0.955 0.975 0.924 0.893 0.804 0.477
∆SF 0.066 0.071 0.057 0.064 0.051 0.047 0.029
Surviving fraction corrected for 
multiplicity: f 0.846 0.902 0.943 0.846 0.796 0.672 0.342
∆f 0.113 0.138 0.122 0.110 0.079 0.060 0.024
December 5, 2002
Plating efficiency PE=
 
 
T-47Dmix, 0.3 Gy  primer with dose rate 0.045 Gy/h, 6 hour interval
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Experiment: T16/24
Multiplicity M= 1.530 0.45667
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 126 130 123 130 128 131 194 218
flask 2 118 142 134 127 115 107 172 214
flask 3 171 128 131 119 116 122 142 214
flask 4 137 125 145 154 100 116 162 194
flask 5 133 123 130 153 117 118 138 186
Number of cells seeded per flask 300 300 300 300 300 300 400 800
Mean number of colonies per flask: N 137.0 129.6 132.6 136.6 115.2 118.8 161.6 205.2
∆N 9.09 3.33 3.59 7.13 4.47 3.92 10.24 6.37
Number of cells seeded multiplied with 
PE: N0 137 137 137 137 137 182.667 365.333
∆N0 9.094 9.094 9.094 9.094 9.094 12.125 24.251
Surviving fraction: SF 0.946 0.968 0.997 0.841 0.867 0.885 0.562
∆SF 0.067 0.069 0.084 0.065 0.064 0.081 0.041
Surviving fraction corrected for 
multiplicity: f 0.897 0.936 0.994 0.739 0.775 0.800 0.432
∆f 0.116 0.129 0.177 0.087 0.091 0.119 0.038
January 15, 2003
Plating efficiency PE=
 
 
Experiment: T18/24
Multiplicity M= 1.516 0.595
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 113 124 118 90 120 126 148 194
flask 2 126 139 138 139 108 122 142 198
flask 3 128 121 129 117 104 106 144 180
flask 4 117 113 121 113 101 112 142 183
flask 5 111 124 113 106 122 106 163 189
Number of cells seeded per flask 200 200 200 200 200 200 300 600
Mean number of colonies per flask: N 119.0 124.2 123.8 113.0 111.0 114.4 147.8 188.8
∆N 3.42 4.21 4.40 7.97 4.24 4.12 3.95 3.34
Number of cells seeded multiplied with 
PE: N0 119 119 119 119 119 178.5 357
∆N0 3.421 3.421 3.421 3.421 3.421 5.131 10.262
Surviving fraction: SF 1.044 1.040 0.950 0.933 0.961 0.828 0.529
∆SF 0.046 0.048 0.072 0.045 0.044 0.033 0.018
Surviving fraction corrected for 
multiplicity: f 1.101 1.093 0.905 0.877 0.926 0.725 0.404
∆f 0.122 0.122 0.124 0.073 0.079 0.042 0.016
January 22, 2003
Plating efficiency PE=
 
T-47Dmix, 0.3 Gy  primer with dose rate 0.045 Gy/h, 24 hour interval
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VII: T-47D, primed by incorporated tritium, 0.01 Gy/h, 
before acute irradiation.  
 
Experiment: T12
Multiplicity M= 1.332 0.381
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 176 163 147 156 137 108 142 110
flask 2 152 146 156 113 127 137 132 90
flask 3 169 147 140 132 124 127 136 86
flask 4 151 175 175 135 130 161 161 88
flask 5 114 161 159 125 154 138 161 82
Number of cells seeded per flask 400 400 400 400 400 400 600 1000
Mean number of colonies per flask: N 152.4 158.4 155.4 132.2 134.4 134.2 146.4 91.2
∆N 10.75 5.42 5.94 7.05 5.35 8.60 6.17 4.88
Number of cells seeded multiplied with 
PE: N0 152.4 152.4 152.4 152.4 152.4 228.6 381
∆N0 10.745 10.745 10.745 10.745 10.745 16.118 26.863
Surviving fraction: SF 1.039 1.020 0.867 0.882 0.881 0.640 0.239
∆SF 0.081 0.082 0.077 0.071 0.084 0.053 0.021
Surviving fraction corrected for 
multiplicity: f 1.061 1.030 0.818 0.836 0.835 0.559 0.189
∆f 0.130 0.126 0.097 0.092 0.108 0.055 0.018
November 28, 2002
Plating efficiency PE=
 
 
Experiment: T17
Multiplicity M= 1.167 0.2395
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5
flask 1 105 102 80 91 95 80 107 49
flask 2 100 99 88 89 92 84 83
flask 3 99 108 94 94 116 81 126
flask 4 92 87 108 96 99 72 114
flask 5 83 98 116 98 96 84 112
Number of cells seeded per flask 400 400 400 400 400 400 600 1000
Mean number of colonies per flask: N 95.8 98.8 97.2 93.6 99.6 80.2 108.4 49.0
∆N 3.81 3.43 6.56 1.63 4.25 2.20 7.08
Number of cells seeded multiplied with 
PE: N0 95.8 95.8 95.8 95.8 95.8 143.7 239.5
∆N0 3.813 3.813 3.813 3.813 3.813 5.720 9.533
Surviving fraction: SF 1.031 1.015 0.977 1.040 0.837 0.754 0.205
∆SF 0.054 0.080 0.042 0.061 0.040 0.058 0.008
Surviving fraction corrected for 
multiplicity: f 1.038 1.018 0.973 1.048 0.812 0.721 0.180
∆f 0.066 0.096 0.050 0.074 0.045 0.062 0.007
January 17, 2003
Plating efficiency PE=
 
 
 T-47D, primed by incorporated tritium, 0.01 Gy/h
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VIII: T-47Dmix, acute irradiation, no priming dose. 
 
Experiment: T20
Multiplicity M= 1.447 0.376
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5 7.5 10
flask 1 71 57 59 78 65 79 69 58 29 10
flask 2 88 73 55 52 68 57 88 79 28 10
flask 3 73 70 72 53 57 72 82 57 44 16
flask 4 65 57 60 58 57 47 61 68 39 12
flask 5 79 69 58 49 53 69 63 52 18
Number of cells seeded per flask 200 200 200 200 200 200 300 600 1500 5000
Mean number of colonies per flask: N 75.2 65.2 60.8 58.0 61.8 61.6 73.8 65.0 38.4 13.2
∆N 3.90 3.41 2.92 5.21 2.81 6.00 4.89 4.01 4.55 1.62
Number of cells seeded multiplied with 
PE: N0 75.2 75.2 75.2 75.2 75.2 112.8 225.6 564 1880
∆N0 3.904 3.904 3.904 3.904 3.904 5.856 11.712 29.279 97.596
Surviving fraction: SF 0.867 0.809 0.771 0.821 0.819 0.654 0.288 0.068 0.007
∆SF 0.064 0.057 0.080 0.057 0.090 0.055 0.023 0.009 0.001
Surviving fraction corrected for 
multiplicity: f 0.794 0.718 0.673 0.734 0.731 0.543 0.213 0.048 0.005
∆f 0.087 0.071 0.095 0.072 0.114 0.057 0.018 0.006 0.001
January 27, 2003
Plating efficiency PE=
 
 
Experiment: T21
Multiplicity M= 1.254 0.466
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5 7.5 10
flask 1 98 104 99 73 75 83 94 109 61 106
flask 2 81 86 85 89 64 87 118 116 69 72
flask 3 93 83 84 81 69 89 124 108 85 71
flask 4 99 86 102 82 75 95 114 123 68 52
flask 5 95 89 97 82 84 75 114 125 96 89
Number of cells seeded per flask 200 200 200 200 200 200 300 600 1500 5000
Mean number of colonies per flask: N 93.2 89.6 93.4 81.4 73.4 85.8 112.8 116.2 75.8 78.0
∆N 3.23 3.72 3.72 2.54 3.36 3.32 5.04 3.48 6.40 9.13
Number of cells seeded multiplied with 
PE: N0 93.2 93.2 93.2 93.2 93.2 139.8 279.6 699 5662.65
∆N0 3.231 3.231 3.231 3.231 3.231 4.847 9.693 24.233 6566.265
Surviving fraction: SF 0.961 1.002 0.873 0.788 0.921 0.807 0.416 0.108 0.014
∆SF 0.052 0.053 0.041 0.045 0.048 0.046 0.019 0.010 0.016
Surviving fraction corrected for 
multiplicity: f 0.949 1.003 0.839 0.739 0.897 0.761 0.357 0.088 0.011
∆f 0.067 0.071 0.049 0.051 0.060 0.053 0.018 0.008 0.013
January 30, 2003
Plating efficiency PE=
 
 
Experiment: T22
Multiplicity M= 1.056 0.32
Dose (Gy) Control 0.1 0.2 0.5 0.75 1 2 5 7.5 10
flask 1 59 73 38 66 43 95 53 54 23
flask 2 56 59 62 47 47 50 91 50 37 16
flask 3 76 68 45 42 44 54 67 69 52 15
flask 4 67 69 52 52 56 76 64 34 11
flask 5 57 58 46 51 61 68 63 59 23
Number of cells seeded per flask 200 200 200 200 200 200 300 600 1500 5000
Mean number of colonies per flask: N 64.0 62.6 55.6 46.0 54.8 49.0 79.4 59.8 47.2 17.6
∆N 4.71 2.42 5.30 2.66 4.14 3.21 5.80 3.57 4.93 2.36
Number of cells seeded multiplied with 
PE: N0 64 64 64 64 64 96 192 3313.95 11046.5
∆N0 4.708 4.708 4.708 4.708 4.708 7.062 14.124 1848.837 6162.791
Surviving fraction: SF 0.978 0.869 0.719 0.856 0.766 0.827 0.311 0.014 0.002
∆SF 0.081 0.105 0.067 0.090 0.075 0.086 0.030 0.008 0.001
Surviving fraction corrected for 
multiplicity: f 0.977 0.862 0.707 0.849 0.755 0.819 0.300 0.014 0.002
∆f 0.086 0.109 0.069 0.094 0.078 0.089 0.029 0.008 0.001
January 31, 2003
Plating efficiency PE=
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 T-47Dmix, acute irradiation
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IX: V 79, acute irradiation, no priming dose. 
 
Experiment: V 1
Multiplicity M= 1.052 0.605
Dose (Gy) Control 0.5 1 2 5.1 7.7 10.2 14.4
flask 1 114 100 117 201 97 125 85 43
flask 2 144 103 108 176 115 131 99 36
flask 3 125 95 118 191 130 129 89 37
flask 4 96 128 119 189 124 167 113 37
flask 5 126 143 93 184 124 128 57
Number of cells seeded per flask 200 200 200 400 600 1500 4000 20000
Mean number of colonies per flask: N 121.0 113.8 111.0 188.2 116.5 135.2 102.8 42.0
∆N 7.89 9.26 4.91 4.12 7.19 8.05 7.94 3.95
Number of cells seeded multiplied with 
PE: N0 121 121 242 363 907.5 2420 12100
∆N0 7.887 7.887 15.773 23.660 59.150 157.734 788.670
Surviving fraction: SF 0.940 0.917 0.778 0.321 0.149 0.042 0.003
∆SF 0.098 0.072 0.053 0.029 0.013 0.004 0.000
Surviving fraction corrected for 
multiplicity: f 0.937 0.913 0.768 0.310 0.143 0.040 0.003
∆f 0.103 0.075 0.055 0.028 0.013 0.004 0.000
February 7, 2002
Plating efficiency PE=
 
 
Experiment: V 2
Multiplicity M= 1.144 0.71
Dose (Gy) Control 0.5 1 2 5.1 7.7 10.2 14.4
flask 1 138 128 82 191 166 185 137 76
flask 2 165 134 161 190 151 143 93 56
flask 3 140 114 106 202 162 154 106 44
flask 4 136 103 118 207 134 179 123 49
flask 5 131 106 143 194 174 150 100 66
Number of cells seeded per flask 200 200 200 400 600 1500 4000 20000
Mean number of colonies per flask: N 142.0 117.0 122.0 196.8 157.4 162.2 111.8 58.2
∆N 5.94 6.07 13.85 3.31 6.93 8.33 8.02 5.78
Number of cells seeded multiplied with 
PE: N0 142 142 284 426 1065 2840 14200
∆N0 5.941 5.941 11.883 17.824 44.560 118.828 594.138
Surviving fraction: SF 0.824 0.859 0.693 0.369 0.152 0.039 0.004
∆SF 0.055 0.104 0.031 0.022 0.010 0.003 0.000
Surviving fraction corrected for 
multiplicity: f 0.801 0.840 0.661 0.337 0.135 0.035 0.004
∆f 0.060 0.115 0.033 0.021 0.009 0.003 0.000
February 14, 2002
Plating efficiency PE=
 
 
Experiment: V 3
Multiplicity M= 1.067 0.907
Dose (Gy) Control 0.5 1 2 5.1 7.7 10.2 14.4
flask 1 205 149 162 261 214 112 150 48
flask 2 173 197 162 249 190 101 140 56
flask 3 204 141 151 294 174 131 109 69
flask 4 157 168 194 257 213 91 151 73
flask 5 168 171 160 292 160 149 146 57
Number of cells seeded per flask 200 200 200 400 600 1500 4000 20000
Mean number of colonies per flask: N 181.4 165.2 165.8 270.6 190.2 116.8 139.2 60.6
∆N 9.78 9.75 7.34 9.35 10.63 10.43 7.79 4.57
Number of cells seeded multiplied with 
PE: N0 181.4 181.4 362.8 544.2 1360.5 3628 18140
∆N0 9.781 9.781 19.561 29.342 73.354 195.612 978.059
Surviving fraction: SF 0.911 0.914 0.746 0.350 0.086 0.038 0.003
∆SF 0.073 0.064 0.048 0.027 0.009 0.003 0.000
Surviving fraction corrected for 
multiplicity: f 0.905 0.908 0.733 0.335 0.081 0.036 0.003
∆f 0.077 0.067 0.049 0.027 0.008 0.003 0.000
February 28, 2002
Plating efficiency PE=
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Experiment: V 4
Multiplicity M= 1.066 0.88
Dose (Gy) Control 0.1 0.2 0.5 0.8 1 2 5.12
flask 1 176 184 146 192 159 140 264 162
flask 2 183 172 164 175 150 159 233 178
flask 3 164 176 163 165 165 168 233 139
flask 4 175 160 156 150 159 170 229 180
flask 5 182 172 148 151 149 140 230 190
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 176.0 172.8 155.4 166.6 156.4 155.4 237.8 169.8
∆N 3.39 3.88 3.71 7.87 3.03 6.55 6.60 8.91
Number of cells seeded multiplied with 
PE: N0 176 176 176 176 176 352 704
∆N0 3.391 3.391 3.391 3.391 3.391 6.782 13.565
Surviving fraction: SF 0.982 0.883 0.947 0.889 0.883 0.676 0.241
∆SF 0.029 0.027 0.048 0.024 0.041 0.023 0.013
Surviving fraction corrected for 
multiplicity: f 0.981 0.876 0.943 0.882 0.876 0.661 0.229
∆f 0.031 0.029 0.051 0.026 0.043 0.023 0.013
March 3, 2002
Plating efficiency PE=
 
 
Experiment: V 5
Multiplicity M= 1.042 0.568
Dose (Gy) Control 0.1 0.2 0.5 0.8 1 2 5.12
flask 1 104 122 114 122 113 99 153 101
flask 2 117 94 127 111 109 108 158 144
flask 3 106 102 113 112 108 116 170 133
flask 4 127 97 105 104 94 111 148 149
flask 5 114 100 97 99 105 81 140 129
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 113.6 103.0 111.2 109.6 105.8 103.0 153.8 131.2
∆N 4.13 4.94 5.00 3.91 3.22 6.16 5.02 8.37
Number of cells seeded multiplied with 
PE: N0 113.6 113.6 113.6 113.6 113.6 227.2 454.4
∆N0 4.130 4.130 4.130 4.130 4.130 8.261 16.522
Surviving fraction: SF 0.907 0.979 0.965 0.931 0.907 0.677 0.289
∆SF 0.055 0.057 0.049 0.044 0.063 0.033 0.021
Surviving fraction corrected for 
multiplicity: f 0.903 0.978 0.963 0.929 0.903 0.668 0.280
∆f 0.056 0.059 0.051 0.046 0.066 0.034 0.021
April 4, 2002
Plating efficiency PE=
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Experiment: V 6
Multiplicity M= 1.042 0.755
Dose (Gy) Control 0.1 0.2 0.5 0.8 1 2 5.12
flask 1 158 156 146 136 133 140 217 185
flask 2 152 151 151 141 143 143 220 188
flask 3 144 161 153 137 132 145 242 196
flask 4 144 145 141 139 141 146 215 182
flask 5 157 145 132 125 147 138 197 226
Number of cells seeded per flask 200 200 200 200 200 200 400 800
Mean number of colonies per flask: N 151.0 151.6 144.6 135.6 139.2 142.4 218.2 195.4
∆N 3.03 3.12 3.78 2.79 2.91 1.50 7.18 8.00
Number of cells seeded multiplied with 
PE: N0 151 151 151 151 151 302 604
∆N0 3.033 3.033 3.033 3.033 3.033 6.066 12.133
Surviving fraction: SF 1.004 0.958 0.898 0.922 0.943 0.723 0.324
∆SF 0.029 0.032 0.026 0.027 0.021 0.028 0.015
Surviving fraction corrected for 
multiplicity: f 1.004 0.956 0.894 0.919 0.941 0.714 0.315
∆f 0.030 0.033 0.027 0.028 0.022 0.028 0.015
April 10, 2002
Plating efficiency PE=
 
 
 
 
V-79 acute irradiation (small doses)
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X: NHIK 3025, acute irradiation, no priming dose. 
 
Experiment: N1
Multiplicity M= 1.17031 0.666
Dose (Gy) control 0.1 0.2 0.5 0.75 1 2 5
flask 1 121 119 150 131 135 131 202 288
flask 2 124 130 161 131 138 144 173 311
flask 3 155 151 146 131 129 145 219 308
flask 4 126 137 140 134 125 148 178 284
flask 5 140 132 132 126 129 116 192 309
Number of cells seeded per flask 200 200 200 200 200 200 400 2000
Mean number of colonies per flask: N 133.2 133.8 145.8 130.6 131.2 136.8 192.8 300.0
∆N 6.35 5.21 4.86 1.29 2.33 5.96 8.32 5.77
Number of cells seeded multiplied with 
PE: N0 133.2 133.2 133.2 133.2 133.2 266.4 1332
∆N0 6.351 6.351 6.351 6.351 6.351 12.703 63.514
Surviving fraction: SF 1.005 1.095 0.980 0.985 1.027 0.724 0.225
∆SF 0.062 0.064 0.048 0.050 0.066 0.047 0.012
Surviving fraction corrected for 
multiplicity: f 1.005 1.117 0.977 0.982 1.033 0.687 0.198
∆f 0.075 0.081 0.057 0.060 0.081 0.050 0.011
February 11, 2003
Plating efficiency PE=
 
 
Experiment: N2
Multiplicity M= 1.11163 0.569
Dose (Gy) control 0.1 0.2 0.5 0.75 1 2 5
flask 1 103 111 122 122 92 91 137 174
flask 2 103 120 121 103 105 100 158 155
flask 3 110 110 123 108 116 99 156 191
flask 4 137 117 106 114 108 109 138 197
flask 5 116 117 125 124 93 109 140 201
Number of cells seeded per flask 200 200 200 200 200 200 400 2000
Mean number of colonies per flask: N 113.8 115.0 119.4 114.2 102.8 101.6 145.8 183.6
∆N 6.29 1.92 3.41 4.00 4.58 3.40 4.61 8.51
Number of cells seeded multiplied with 
PE: N0 113.8 113.8 113.8 113.8 113.8 227.6 1138
∆N0 6.288 6.288 6.288 6.288 6.288 12.576 62.881
Surviving fraction: SF 1.011 1.049 1.004 0.903 0.893 0.641 0.161
∆SF 0.058 0.065 0.066 0.064 0.058 0.041 0.012
Surviving fraction corrected for 
multiplicity: f 1.012 1.056 1.004 0.893 0.881 0.614 0.147
∆f 0.066 0.075 0.074 0.070 0.063 0.042 0.011
February 12, 2003
Plating efficiency PE=
 
 
Experiment: N3
Multiplicity M= 1.01498 0.786
Dose (Gy) control 0.1 0.2 0.5 0.75 1 2 5
flask 1 153 163 136 146 131 108 174 139
flask 2 151 176 157 128 137 111 197 136
flask 3 168 138 156 140 139 129 178 138
flask 4 148 137 137 137 131 169 138
flask 5 166 160 144 132 116 158 142
Number of cells seeded per flask 200 200 200 200 200 200 400 2000
Mean number of colonies per flask: N 157.2 154.8 149.7 139.0 135.2 119.0 175.2 138.6
∆N 4.09 7.56 6.84 3.16 1.56 4.68 6.40 0.98
Number of cells seeded multiplied with 
PE: N0 157.2 157.2 157.2 157.2 157.2 314.4 1572
∆N0 4.091 4.091 4.091 4.091 4.091 8.183 40.915
Surviving fraction: SF 0.985 0.952 0.884 0.860 0.757 0.557 0.088
∆SF 0.054 0.050 0.031 0.024 0.036 0.025 0.002
Surviving fraction corrected for 
multiplicity: f 0.985 0.951 0.883 0.858 0.754 0.554 0.087
∆f 0.055 0.051 0.031 0.025 0.036 0.025 0.002
February 14, 2003
Plating efficiency PE=
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APPENDIX E: Dose-response curves with 
calculated mean values of survival fraction 
 
 
 
 
 
Mean surviving fraction of three independent experiments
           for T-47D, T-47Dmix, and NHIK 3025 cells
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Mean values of surviving fraction 
      for T-47D cells, not pre-irradiated (three experiments) and 
T-47D cells, pre-irradiated by incorporated tritium (two experiments)
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Mean values of surviving fraction 
      for T-47D cells, not pre-irradiated (three experiments) and 
T-47D cells, pre-irradiated by incorporated tritium (two experiments)
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Mean values of surviving fraction 
      for T-47D cells, not pre-irradiated (three experiments) and 
T-47D cells with HDR priming dose of 0.3 Gy (two experiments)
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      for T-47D cells, not pre-irradiated (three experiments) and 
T-47D cells with HDR priming dose of 0.3 Gy (two experiments)
Dose (Gy)
0 1 2
Su
rv
iv
in
g 
fra
ct
io
n
0,5
0,6
0,7
0,8
0,9
1
unprimed T-47D cells
primed T-47D cells, 0.3 Gy, HDR, 6 hours between doses
primed T-47D cells, 0.3 Gy, HDR, 24 hours between doses
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 T-47Dmix cells, unprimed and with a 0.3 Gy priming dose delivered with 0.045 Gy/h 
 mean values of surviving fraction from three independent experiments. 
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APPENDIX F: Supplementary DNA histograms 
from flow cytometry 
 
 
 
 
 
 
DNA histogram of a cell population of MCF7 cells added to the mixed cell population (T-
47Dmix). Relative cell number is shown as a function of relative DNA content. 
 
 
 
 
 
DNA histogram of a cell population of HU adapted T-47D cells added to the mixed cell 
population (T-47Dmix). Relative cell number is shown as a function of relative DNA content. 
 
 
 
 
 
 
 
 
 
 
 
